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Abstract
This study explored the relationship between certain educational and professional
variables that influence the adherence to empirically supported practices in cognitivebehavioral therapy for insomnia (CBT-I). The variables of interest included the
practitioner’s level of training as measured by the number of hours of advanced training
in CBT-I, the total number of hours practicing CBT-I out of the total annual clinical
practice hours, and the total number of years practicing CBT-I. The final variable of
interest was treatment preference and practice knowledge. The study used a one-time,
cross-sectional, web-based survey. The participants consisted of 165 mental health and
medical professionals of various disciplines who were trained in CBT-I. The results
suggested that individuals with more training were significantly more likely to apply
CBT-I. Practitioners with more training had a higher percentage of CBT-I on their
caseloads than those with less training. The total number of training hours did not
significantly predict adherence, with all practitioners scoring similarly.
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Chapter 1: Introduction
Statement of the Problem
Each year, millions of individuals in the United States report sleeplessness
(Moloney, Konrad, & Zimmer, 2011). Between the years of 1993 and 2007, cases of
insomnia were reported to be as high 5.7 million in the United States (Moloney et al.,
2011). Insomnia impacts life domains, including virtually every single aspect of physical
health and mental health (Kryger & Roth, 2017). Work productivity is particularly
impacted by insomnia, with complaints of insomnia being the most common reason for
missing work (Leigh, 1991). The net cost of absenteeism includes lost revenue and
increased costs for medical treatments. The annual estimated cost of treating insomnia is
between 30 and 35 million dollars, with some reports as high as 170 million dollars
(Wickwire, 2015).
Some individuals may regard medication as the most—or only—effective
treatment for insomnia. Prescription medications written for insomnia increased 21 times
faster than reported sleeplessness complaints and 5 times faster than newly diagnosed
cases of insomnia between the years 1993 and 2007 (Moloney et al., 2011). The statistics
suggest that an emphasis is placed on prescription medication when treating insomnia
among the public and medical professionals (Moloney et al., 2011). As an example, in
2003, the majority of the money spent to treat insomnia among Medicaid recipients in the
state of West Virginia was used for medication, with as much as 88% of prescription drug
treatment involving Zolpidem and Trazodone, and 84% of total dollars spent on insomnia
prescriptions going to Zolpidem (Roy & Smith, 2010). This information is important

EVIDENCE BASED CBT-I

2

because it suggests that a large number of individuals experiencing symptoms of
insomnia are being treated with pharmacological interventions.
Despite high rates of pharmacological treatment for insomnia, there are effective
interventions that do not require medication (Wilson & Nutt, 2014). For example, the
success of cognitive and behavioral interventions for insomnia is as high as 80% (Morin,
2005). Evidence shows that cognitive-behavioral interventions can be more effective
(Homsey & O’Connell, 2012), longer lasting (Riemann & Perlis, 2009), and more cost
effective than pharmacological interventions alone (Tannenbaum et al., 2015).
Combining medication and cognitive-behavioral therapy (CBT) appears to maximize the
effects of both and expedites the time to positive outcomes when treating insomnia
(Milby et al., 1993). Research shows that the inclusion of cognitive-behavioral
interventions for insomnia also increases the durability of treatment (McClusky, Milby,
Switzer, Williams, & Wooten, 1991). The question remains, however: Are mental health
and medical practitioners using evidence-based interventions, which are considered best
practice, in the treatment of insomnia?
To answer any question related to proper application of evidence-based treatment,
an exploration of the variables that determine therapeutic outcomes is necessary.
Research indicates that formal education and the use of structured questionnaires increase
the accuracy of diagnosing insomnia (Backhaus et al., 2002). This information is
particularly relevant because increased diagnostic accuracy has been shown to have a
positive correlation with treatment outcomes across diagnoses (Jensen-Doss & Weisz,
2008). Although diagnostic accuracy does not seem to change significantly based solely
on the number of years of experience (Spengler & Pilipis, 2015), treatment outcomes
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have been shown to be influenced by the level of experience and the therapist’s level of
education, with more experienced graduate level practitioners achieving higher patient
adherence and global performance rates than those achieved by lower level practitioners
(Stein & Lambert, 1995). This information might indicate that patients who see more
experienced practitioners tend to receive more effective treatment. Research also shows
that experience applying CBT increases the effectiveness of therapeutic interventions, as
evidenced by a reduction in unwanted symptoms (Forand, Evans, Haglin, & Fishman,
2011). In summary, the literature indicates that a practitioner’s training, experience, and
knowledge influence the application of evidence-based treatment and outcome; however,
many practitioners report a lack of training in cognitive-behavioral interventions for
insomnia (Meltzer, Phillips, & Mindell, 2009). The research regarding the efficacy of
CBT for insomnia (CBT-I) demonstrates how effective it is in reducing symptoms of
insomnia. Nevertheless, the topic of how practitioners apply CBT-I has not been
researched extensively.
CBT-I is a therapeutic modality designed to use cognitive and behavioral methods
to reduce variance in circadian rhythm and use homeostatic mechanisms to assist people
in attaining more consistent and restorative sleep (Wilson & Nutt, 2014). Even brief
CBT-I patient workshops are highly effective in reducing insomnia (Swift et al., 2012).
Nonpharmacological behavioral interventions employed in CBT-I include sleep
restriction, stimulus control, and sleep hygiene. Stimulus control utilizes behavioral
techniques to intentionally manipulate paired stimuli that are associated with the onset of
sleep (Bootzin, 1973; Bootzin & Rider, 1997). Sleep restriction involves reducing naps,
delaying bedtime, or advancing bedtime in order to normalize sleep wake patterns
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(Spielman, Saskin, & Thorpy, 1987). Both sleep restriction and stimulus control have
been researched extensively and determined to be efficacious (Kierlin, 2008). In addition,
sleep hygiene, which often involves instructions for patients to use elements of both
stimulus control and sleep restriction, is reported by individuals in treatment to be more
effective than medication (Homsey & O’Connell, 2012).
In CBT-I, cognitive intervention strategies are employed in addition to behavioral
interventions, because negative thought patterns are associated with a higher risk of
developing and maintaining insomnia. Negative thoughts that occur prior to sleep onset
or during the course of the day are associated with higher rates of insomnia symptoms.
CBT-I focuses on challenging distortions in thinking in order to reduce anxiety and
promote restorative sleep (Baker, Baldwin, & Garner, 2015).
When implemented effectively, these behavioral and cognitive techniques
decrease insomnia symptoms. Despite the clear efficacy of nonpharmacological
interventions, many medical and mental health professionals do not receive education on
sleep disorders and behavioral sleep medicine. The lack of formal education reduces
therapeutic options and impacts the frequency with which practitioners apply empirically
supported interventions for insomnia.
Graduate education in sleep disorders and evidence-based behavioral
interventions for insomnia is limited (Moline & Zendell, 1993). Including training in
behavioral sleep medicine across disciplines could increase the effectiveness of diagnosis
and treatment of sleep disorders such as insomnia. The research shows a discrepancy
between student professions and specialties. Specifically, 32% of doctoral level
psychology students reported that they received education on sleep medicine in 1993
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compared to 58% of medical students in family practice, 65% of medical students
studying pediatrics, and 87% of medical students studying neurology (Moline & Zendell,
1993). In 1998, a poll was taken of all American Psychological Association psychology
programs in the United States. The results showed that 81% of the psychology programs
had no training in behavioral sleep medicine. Fourteen percent of the programs offered
minimal training in behavioral sleep medicine and, of those programs, 5% had systematic
training (Lichstein et al., 1998). By 2009, 31% of the training programs in the United
States offered formal training for sleep disorders. Of these, only 16% had faculty trained
in sleep medicine (Meltzer et al., 2009). Research indicates that receiving formal,
structured training in CBT-I increases practitioners’ self-efficacy delivering CBT-I and
also improves their attitudes regarding the perceived efficacy of CBT-I (Manber et al.,
2013).
Purpose of the Study
The purpose of this study was to explore whether, and to what degree, the
application of CBT-I differs depending on the practitioner’s level of education, clinical
specialty, and experience. In addition, this study explored clinician-related variables that
influence the practice preferences, practice approach and knowledge, and practice density
of CBT-I.
To date, few researchers have explored the way a practitioner’s preferences and
approach to practice impact the application of CBT-I. Knowing which training
modalities and education-related variables influence the application of CBT-I would
allow for a more efficient educational sequence in higher education. Such knowledge
could also promote more efficient learning during postgraduate workshops. Moreover,
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efficient clinical application of CBT-I could decrease the net cost of mental health and
medical treatment of insomnia by making therapeutic interventions more time limited and
effective.

7
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Chapter 2: Literature Review
Insomnia
The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5; American Psychiatric Association [APA], 2013) defines insomnia as “a
dissatisfaction with sleep quantity or quality with complaints of difficulty initiating or
maintaining sleep” (p. 362). Difficulty initiating or maintaining sleep must cause
clinically significant distress or impairment in social, occupational, educational,
behavioral, or other areas of life (APA, 2013). To diagnose difficulties, the impairment
in sleep must be present for a minimum of 3 nights per week and last at least 3 months
(APA, 2013). The Centers for Disease Control and Prevention (CDC; 2015) further
specifies symptoms of early morning awakenings and an inability to go back to sleep
once awakened. The symptoms of insomnia are diverse and can cause impairments in
physical and mental health (Fortier-Brochu, Beaulieu-Bonneau, Ivers, & Morin, 2010;
Gaultney, 2010; Lovato & Gradisar, 2014).
Common characteristics of insomnia include decreased or nonrestorative sleep
(Pillai, Roth, & Drake, 2016). The DSM-5 diagnostic criteria (APA, 2013), the tenth
edition of the International Statistical Classification of Diseases and Related Health

Problems (ICD-10; World Health Organization [WHO], 2010), and the second edition of
the International Classification of Sleep Disorders (ICSD-2; American Academy of
Sleep Medicine [AASM], 2001) have different criteria for diagnosing symptoms of
insomnia (Gupta et al., 2014). A major difference between the DSM-5, ICD-10, and
ICSD-2 is that symptoms are arranged according to etiology in the ICD-10 and ICSD-2,
whereas in the DSM-5, all types of insomnia are categorized together (Gupta et al., 2014).
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Further, the DSM-5 diagnostic criteria allow for the recognition of insomnia as an
independent diagnosis (Gupta et al., 2014). In contrast, the ICD-10 and the ICSD-2
categorize the etiology according to organic or nonorganic insomnia, which are also
referred to as primary insomnia versus secondary insomnia, respectively (Pallesen,
Nordhus, Havik, & Nielsen, 2001). Organic refers to a biological cause of insomnia.
Nonorganic refers to psychological or environmental causes of insomnia. In summary,
three diagnostic sets of criteria are used for studying, assessing, and treating the same
disorder. The differences in diagnostic criteria is particularly relevant because accurate
assessment and diagnosis can increase the efficiency of selecting appropriate therapeutic
interventions (Jensen-Doss & Weisz, 2008). Although agreement on symptom
classification is preferred, the consensus appears to be mixed on what those symptoms
are when diagnosing insomnia. Debate in the field of psychology also surrounds specific
subtypes of insomnia (Gupta et al., 2014).
Two proposed categories for diagnostic subtypes of insomnia include a category
that is based on physiological hyperarousal and another that is associated with emotional,
cognitive, and cortical arousal (Gupta et al., 2014). Edinger et al. (2011) explored the
reliability and validity of existing diagnostic subtypes of insomnia in the DSM-IV-TR
(APA, 2000) and the ICSD-2. The categories with the best validity in the DSM-IV-TR
were insomnia related to another mental disorder, insomnia resulting from a general
medical condition, breathing-related sleep disorder, and circadian-rhythm sleep disorder.
The categories with the most validity in the ICSD-2 included insomnia related to a mental
disorder, insomnia related to a medical condition, obstructive sleep apnea, restless legs
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syndrome, idiopathic insomnia, and circadian-rhythm sleep disorder-delayed sleep phase
type (Edinger et al., 2011).
Although unanimous agreement between the DSM-5, ICSD-2, and ICD-10 has not
yet been achieved, many of these symptoms are common among different populations in
the United States, and high rates of insomnia have also been noted among other countries
(Soldatos, Allaert, Ohta, & Dikeos, 2005). Owing to the frequency of insomnia occurring
in various populations globally, one could hypothesize that it may share a common
etiology or etiologies worldwide.
Prevalence. Prevalence describes the proportion of individuals in a given
population who have a particular condition at a given time, whereas rates describe the
frequency with which those conditions occur in a specific sample. Although the rates of
insomnia are different among studies, insomnia occurs in many populations globally. In
one study, Brazil, South Africa, and Belgium reported the highest rates of insomnia:
79.8%, 45.3%, and 36.0%, respectively (Soldatos et al., 2005). These percentages
represent acute insomnia symptoms as measured by the Athens Insomnia Scale (AIS).
The term acute refers to one time point over the course of a lifetime as opposed to
lifetime prevalence. Other research assessing acute symptoms of insomnia over a 12month period found that the highest rates of “sleeping problems” occur in the United
States, followed by Western Europe and Japan, with 56%, 31%, and 23% of participants
respectively reporting sleep problems (Léger, Poursain, Neubauer, & Uchiyama, 2008).
In the United States, the rates of insomnia by ethnicity are 10% among
Caucasians, 7% among Hispanics, 4% among Asians, and 3% among African Americans
(Morin & Jarrin, 2013). Su, Huang, and Chou (2004) reported that 6% of Taiwanese
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adults over the age of 65 years experienced insomnia for at least 1 month and that 17.7%
met criteria for insomnia symptoms over the course of their lifetimes. Similar rates of
diagnosis were found in Canada, with 25.3% of individuals surveyed reporting a
dissatisfaction with their sleep, 29.9% reporting some symptoms of insomnia, and 9.5%
meeting criteria for insomnia (Morin, LeBlanc, Daley, Gregoire, & Mérrette, 2006).
The reason the rates of insomnia differ between samples and geographic
locations is unknown. One explanation could be the different measurements used by
different researchers. Some experiments relied on DSM-IV-TR diagnostic criteria,
whereas others based their findings on alternative measurements, such as the AIS or
Epworth Sleepiness Scale (ESS). DSM-IV-TR and ICD-10 diagnostic criteria are
considered more precise and stringent, as they measure frequency and severity, in
contrast with other, more liberal measures that do not account for frequency and severity
(Morin et al. 2006).
Although the numbers may vary depending on demographic information or
physical location, sufficient evidence shows that the impact of insomnia can be severe in
a variety of domains, regardless of geographic location (Soldatos et al., 2005) or ethnicity
(Morin & Jarrin, 2013). Evidence also shows that particular personality traits may
predispose individuals to develop insomnia (Vincent & Walker, 2000).
Risk factors. Risk factors for insomnia include sleep reactivity, stress reactivity,
and neuroticism. Sleep reactivity is defined as a greater sleep difficulty following a
challenging event (Vargas, Friedman, & Drake, 2015). Sleep reactivity relates to the way
individuals process events in their lives and can be conceptualized as a higher baseline
response to stress, leading to a higher tendency to develop insomnia (Harvey, Gehrman,
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& Espie, 2014). Similar to sleep reactivity, stress reactivity, which is a higher baseline
response to stressful life events, is also associated with a higher rate of neuroticism
(Harvey, Gehrman, et al., 2014). The personality trait of neuroticism is associated with
increased rates of insomnia (Levin, Bertelson, & Lacks, 1984; Vincent & Walker, 2001.
Trauma is also associated with higher risk for developing insomnia (Sinha, 2016).
Trauma is believed to increase the risk of insomnia both biologically and psychologically.
The experience of stress increases the sensitivity and arousal of the nervous system that
leads to hyperarousal. Hyperarousal decreases an individual’s ability to fall asleep
(Fernandez-Mendoza et al., 2016; Sinha, 2016).
Having a variable work schedule results in abnormal and inconsistent sleep
patterns that are correlated with a higher likelihood of developing insomnia. Two
different phenotypes of insomnia are proposed to develop from shift work: sleepy
insomnia and alert insomnia. In regard to symptom presentations, individuals with sleepy
insomnia are tired but cannot sleep, whereas individuals with alert insomnia are more
cognitively aroused and cannot sleep. Research demonstrates that the sleepy type of
insomnia is explained by circadian misalignment and alert insomnia can be precipitated
by shift work (Gumenyuk, Belcher, Drake & Roth, 2015). Not getting adequate sleep or
getting sleep that is nonrestorative can impact physical health.
Biological Perspectives on Sleep-Wake Cycle Regulation
Insomnia can be caused by biological, psychological, and environmental factors
(Peters, 2014). Furthermore, variables that are endogenous and exogenous can influence
neurotransmitter production. The internal and external processes are categorized into two
groups: the circadian alerting system and the homeostatic sleep drive (Peters, 2014).
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Circadian rhythms. The circadian alerting system refers to external stimuli,
internal cognitions, or behaviors that influence biological functioning (Richardson,
Gradisar, & Barbero-, 2015). The suprachiasmatic nucleus of the hypothalamus is the
locus of the brain that is most responsible for the cycles of wakefulness and sleep
(Lieberman, Neubauer, & Dutch, 2007). The suprachiasmatic nucleus responds to the
external stimuli of light and dark and is involved in hormone and neurotransmitter
production which, in turn, promotes or inhibits sleep. The serotonergic, noradrenergic,
cholinergic, and hypocretin systems are the specific neurotransmitter systems that
influence the sleep-wake cycle (Luppi & Fort, 2011).
Hormones also play a large part in the regulation of sleep. Irregularities in
hormone production can lead to variances in sleep-wake cycles, and variances in sleepwake cycles can also lead to a hormone imbalance (Morgan & Tsai, 2016). Melatonin is
a critical hormone in sleep-wake cycles; melatonin production increases immediately
prior to the onset of somnolence (Golombek, Pandi-Perumal, Brown, & Cardinali, 2015).
Other important hormones include prolactin, gonadrotropic hormones, leptin, and ghrelin.
A full description of each hormone and its function as it relates to sleep is beyond the
scope of this literature review (see Morgan & Tsai, 2016).
The circadian alerting system explains how the environment can influence sleepwake cycles and subjective feeling of fatigue. Elements of the environment and day-today routines that are of great importance include physical activity, amount and intensity
of light, and habituation to stimuli in the environment (Kryger, Thomas, & Dement,
2011).
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Cognitive, behavioral, and environmental variables may lead to increased
cognitive and physiological arousal, as well as dysfunctional beliefs that may interfere
with naturally occurring rhythms of the body that promote sleep onset and maintenance.
An example of cognitions that may impair sleep are those related to excessive worry.
Moreover, one environmental variable that may interfere with sleep is excessive
environmental stimulation such as playing an action-oriented videogame or watching a
highly emotionally arousing movie. Therefore, biological, psychological, and
environmental variables must be taken into account when considering the causes,
assessment, and treatment of insomnia.
In summary, the body has a naturally occurring cycle of sleep and waking that is
referred to as the circadian rhythm, which is regulated by the suprachiasmatic nucleus.
The circadian rhythm can be disrupted by biological processes occurring in the body as
well as external stimuli in the environment. Direct correlates that relate to the
functioning of the suprachiasmatic nucleus may include traumatic brain injuries and other
neurocognitive disorders (Lieberman et al., 2007). Also, something as simple as light,
along with cognition and behavior, can disrupt all varieties of normal functioning,
including sleep.
Homeostasis. The theory of homeostatic sleep drive is based on observations
indicating that virtually all living organisms seem to demonstrate a distinct natural
balance between diurnal and nocturnal activity or, minimally, as in simpler organisms,
periods of activity and quiescence. In higher level organisms, this balance manifests
clearly as sleep and wakefulness. When the balance is upset, a sleep debt accumulates,
thereby offsetting the natural rhythm of sleep and wakefulness. Sleep debt is a term that
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is used to describe an imbalance between an organism’s naturally occurring sleep-wake
cycles. The word debt indicates an imbalance that can be attributed, in large part, to the
neurotransmitters, adenosine, and adrenaline. Long-term sleep debt can negatively
impact the functioning of the brain and directly impact other hormones, neurotransmitters,
and many other processes that influence alertness and somnolence (Kim et al., 2015).
Conversely, sleeping too much can also throw off the endogenous sleep-wake cycles
(Kryger et al., 2011). The variance in organisms’ sleep schedules is particularly relevant
to insomnia. For example, daytime napping can reduce sleep debt and offset naturally
occurring sleep-wake cycles. A variable work schedule, jet lag, or any change in a
naturally occurring or habituated sleep-wake schedule, could also interfere with
homeostasis. Thus, evidence-based interventions, such as sleep restriction, have been
developed to help reestablish these natural rhythms (Kryger et al., 2011).
In summary, the body has an endogenous regulation of wake and sleep. The
balance between wakefulness and sleep is susceptible to changes based on an individual’s
schedule. If changes occur in the form of more or less sleep, the natural balance is offset.
If sleep is lost, a person’s body will naturally attempt to make up that sleep by sleeping
more following the change in schedule. If a person is sleeping too much, such as in the
case of daytime naps, his or her body will regulate the overall sleep total by reducing the
need for sleep, which could result in insomnia.
Models of Insomnia
A number of different models describe the development, etiology, and persistence
of insomnia symptoms. The different models place emphasis on the strength of
biological, psychological, and sociological variables and their influence on insomnia.
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The first model that will be discussed is the stimulus control model. The stimulus
control model, suggests that biological organisms respond to their environments by way
of cues that come to elicit or evoke particular responses through classical and operant
conditioning, respectively. Classical and operant conditioning can elicit specific
physiological, behavioral, emotional, and cognitive responses. In treatment, particular
stimuli and physical elements in the environment can be altered selectively to promote or
inhibit sleep. Examples of stimulus control include selectively altering the amount of
bright light or selectively reducing strenuous activity in proximity to bedtime (Turner &
Ascher,1979; Zwart & Lisman, 1979).
The Speilman model, often referred to as the 3P model, proposes that insomnia
can be explained by understanding relevant predisposing, precipitating, and perpetuating
factors. The Spielman model can be likened to the diathesis-stress model, in which an
organism has a natural predisposition for developing specific symptoms. The
environment and context, such as the onset of a stressor (e.g., losing a job, bereavement,
jet lag) may increase the likelihood that specific genetic predispositions will manifest into
the development of unwanted symptomatology (Perlis, Corbitt, & Kloss, 2014).
The neurocogonitive model suggests that sleep is influenced by various categories
of arousal. These include cortical, cognitive, and somatic arousal. This model is unique
in that it places a stronger emphasis on the biochemical functioning of the brain than do
other models. Essentially, this model asserts that the brain experiences hyperarousal that
conflicts with the normal mesograde amnesia of sleep (Kryger et al., 2011).
The psychobiological inhibition model is similar to the neurocognitive model in
that it emphasizes the biological functioning of the human brain and the influence the
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brain and neurotransmitters have on sleep; however, this model differs from the
neurocognitive model in that it places less of an emphasis on hyperarousal. Instead, the
psychobiological inhibition model attributes the symptoms of insomnia to a failure of the
brain to inhibit wakefulness, suggesting that the symptoms of insomnia may be the result
of the dysregulation of the brain’s natural sleep processes. When the brain is supposed to
be gradually gearing down in order to achieve restful and restorative sleep, it is failing to
do so at the cellular level (Kryger et al., 2011).
The drosophila model places an emphasis on genetics. This model suggests that
the mechanisms of sleep are at least partially susceptible to genetic influence, as
evidenced by higher rates of insomnia occurring in the children of mothers and fathers
who have insomnia. The specific mechanisms described in the drosophila model are the
fight-or-flight response, the plasticity of sleep homeostasis, and circadian processes.
Evidence to support the individual mechanisms and their relatedness to symptoms of
insomnia were tested using animal models. Outcomes of these studies indicated that the
mechanisms of sleep could be influenced over successive generations in a way that leads
to increased variance in endogenous circadian rhythms (Seugnet et al., 2009).
The cage exchange model is another sleep paradigm. The development of this
model used rats to investigate the effects of stress on sleep and the central and autonomic
nervous systems. In these studies, rats transferred from one cage to a separate cage, the
latter of which had been soiled previously by another male rat. Because rats are highly
territorial, this transfer elicited a fight-or-flight response. As a result, each cage
exchanged rat showed increased activity in the cerebral cortex, limbic system, locus
coeruleus, tuberomammillary nucleus, and overall autonomic system. The activation of
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these portions of the brain is believed to contribute sleep impairment and result in
increased sleep variance (Cano, Mochizuki, & Saper, 2008).
Each of these models illustrates differing focuses on the roles of the biology,
psychology, environment, and social behavior on sleep. Each model may lead to a
unique treatment perspective. For example, some medications target the neural
mechanisms of insomnia and treat the symptoms from a biological perspective. Also, a
series of treatments are available that approach the symptoms of insomnia from
psychological and social perspectives.
Impact on Physical Health
Sleep deprivation can impact many important areas of life, as noted in the DSM-5
(APA, 2013; Leigh, 1991; Wickwire, 2015). Common methods for researching the
impact of insomnia rely on objective and subjective measurements. For example, the
severity of sleep disturbance is measured by the number of hours slept, an objective
measure, whereas participant-reported fatigue is a subjective unit of measurement.
In regard to fatigue, individuals who report higher levels of fatigue caused by
insomnia also report greater impairment in health-related quality of life (Fortier-Brochu
et al., 2010). According to Chen, Gelaye, and Williams (2014), quality of life was
inversely related to the level of fatigue reported but not to the objective severity of sleep
disturbance. Sleep disturbances and insomnia presenting as sleep onset latency, middle
awakening, and early waking without the ability to fall asleep again, as well as daytime
fatigue and sleepiness, are all correlated with low health-related quality of life (Chen,
Gelaye, & Williams, 2014).
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Insomnia is a risk factor for decreased immune functioning (Taylor, Lichstein, &
Durrence, 2003). Decreased immune functioning impacts many areas of health,
including cardiovascular disease (Taylor et al., 2003). According to the American Heart
Association (2011), individuals who have trouble falling asleep have a 45% greater
chance of experiencing a heart attacks, individuals who have problems staying asleep
increase heart attack risk by 30%, and individuals who report not feeling refreshed by
sleep have a 27% greater chance of a having a heart attack. Self-reported insomnia is
also associated with rates of coronary heart disease (CHD; Zhuang et al., 2016).
Increased insomnia rates are associated with higher rates of CHD in a population older
than 65 years (Zhuang et al. 2016). Zhuang et al. (2016) found that of the 2,110
participants with CHD, 17.7% had occasional insomnia and 12.17% had frequent
insomnia.
Another important variable linked to physical health is sleep duration. Sleep
duration is an important component in the regulation of metabolism and endocrine
functioning. Specifically, sleep deprivation is linked consistently with obesity (Chen,
Beydoun, & Wang, 2008). Palm, Janson, and Lindberg (2015) found that overweight
individuals experience more insomnia symptoms at baseline. Furthermore, obesity is
commonly associated with diabetes, and decreased sleep duration, which is fewer than 6
consecutive hours of sleep, has been shown to increase the risk of developing Type 2
diabetes (Heianza et al., 2014). The impact of insomnia on weight gain and diabetes has
been explored using animal models. One study demonstrated that increasing sleep
through melatonergic manipulation decreased weight in rats and improved insulin
sensitivity (She et al., 2009). This study demonstrated the differences between weight
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gain and the progression of diabetes through the manipulation of sleep. By increasing
sleep duration, the animal model suggested that both diabetes and weight gain may be
mediated by sleep (She et al., 2009). Physical health is not the only area of health that is
impacted negatively by insomnia; insomnia can impair functioning and mental health in
other areas as well.
Recent literature demonstrates that sleep irregularities, and insomnia specifically,
are associated with a higher risk for developing Alzheimer’s Disease (AD; Cedernaes et
al., 2017). AD develops as a result of a buildup of a substance called amyloid beta that,
in excess, causes plaques and tangles to form in the neuronal architecture of the human
brain. Research has demonstrated that the presence of amyloid beta decreases when
individuals are asleep and that the act of sleeping may offer an important opportunity for
the human body to remove excess amyloid beta in the brain. The human brain has cells,
called glial cells, that are designed specifically to remove waste. Research shows that
individuals who are not getting enough sleep are not affording the cellular mechanisms in
the brain that are responsible for maintenance to function properly, thereby increasing the
human body’s susceptibility to damage through the development of amyloid beta and the
plaques that form as a result of that substance (Cedernaes et al., 2017)
Impact on Adaptive Functioning and Mental Health
Insomnia has a deleterious impact on mental and emotional health. The domains
of cognitive functioning impacted by sleep deprivation impair virtually all aspects of
cognitive processing that are required for higher order thinking. The impairments in
thinking are not isolated to logical function or abstract reasoning, but also impair other
aspects of brain mechanics such as emotional processing.
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Deficits in cognitive functioning. One domain of cognitive functioning that is
impaired by insomnia is psychomotor vigilance (Belenky et al. 2003). Psychomotor
vigilance is a measure of attention and response time. Evidence from sleep restriction
studies has demonstrated that chronic sleep restriction results in decreased psychomotor
vigilance. Psychomotor vigilance deficits can persist once normal sleep is restored in
some cases (Belenky et al. 2003; Van Dongen, Maislin, Mullington, & Dinges, 2003).
Furthermore, the impact of reduced sleep is dose dependent, meaning that the amount of
sleep that is lost is correlated to the impact of the cognitive deficits in performance (Van
Dongen et al., 2003).
Another domain of cognitive functioning that is impacted by insomnia is memory,
specifically, declarative memory and procedural learning (Curcio, Ferrara, & De Gennaro,
2006). Insomnia in older adults has been linked to significantly lower performance in
executive functioning, including verbal memory and working memory (Lo, Groeger,
Cheng, Dijk, & Chee, 2016). These findings are congruent with Shekleton et al. (2014),
who found that patients with insomnia exhibited statistically significant deficits in
switching attention and working memory when compared with patients without insomnia.
Also related to possible memory impairments, college students who reported symptoms
of insomnia were more likely to have a GPA below a 2.0 (Gaultney, 2010). Impairments
in brain functioning may not be limited to performance-related outcomes and could also
impact emotional functioning.
Emotional impact. The relationship between insomnia and mental health
appears to be bidirectional. For instance, longitudinal research has indicated that
insomnia may contribute to the development of depressive symptoms (Okajima, Komada,
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Nomura, Nakashima, & Inoue, 2012; Lovato & Gradisar, 2014). Conversely, depression
may lead to the development of insomnia (Yon et al., 2014). Evidence to support the
complicated relationship between depression and insomnia was elucidated in one study
that examined the impact of therapeutic interventions, such as CBT, for depression and
insomnia. Researchers showed that when depression was treated successfully, the
symptoms of insomnia sometimes also remitted. Treatment of moderate levels of
depression resulted in a decrease in insomnia symptoms. Individuals with higher levels
of depression, however, did not show remission of insomnia, indicating that insomniaspecific interventions may need to be included in treatment regimens to effectively treat
depression and comorbid symptoms, specifically in more severe cases (Yon et al., 2014).
Longitudinal evidence indicating that insomnia can precipitate depression arises
from one such study investigating the development of depression from preexisting
insomnia. Results indicated that the presence of insomnia might predict later depression
(Okajima et al., 2012). Moreover, individuals who displayed persisting insomnia over a
5-year period were significantly more likely to develop symptoms of depression than
individuals who experienced a single episode of insomnia (Suh et al., 2013). Similarly,
individuals in a nonclinical sample who experienced insomnia as assessed by multiple
episodes of insomnia over a 1-year period at baseline were significantly more likely than
a nonclinical sample without insomnia to develop depression over the span of 7.5 years
(Fernandez-Mendoza et al., 2015).
Insomnia has also been shown to increase with frequency when an individual is
experiencing anxiety (Sadigh, Himmanen, & Scepansky, 2014). Among college students,
the presence of state anxiety significantly predicted insomnia (Sadigh et al., 2014). A
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strong correlation also appears to exist between sleep quality and sleep latency, both of
which are symptoms of insomnia and affected by anxiety. Anxiety in the form of sleepspecific worry has been shown to predict sleep onset latency and overall sleep efficiency
(O’Kearney & Pech, 2014).
In summary, insomnia is correlated with anxiety and mood disorders. Insomnia
also takes a toll physically, mentally, and emotionally on individuals who suffer from it.
Symptoms of insomnia have been shown to negatively impact work performance (Léger,
Guilleminault, Bader, Lévy, & Paillard, 2002).
Financial cost. Insomnia has an impact on work performance, with insomnia
being one of the most commonly cited reasons for absenteeism from work (Leigh, 1991).
Individuals with insomnia are twice as likely to miss work than are individuals without
insomnia (Leigh, 1991). According to Ozminkowski, Wang, and Walsh (2007), the
indirect cost of absenteeism was approximately $1,253 greater for individuals with
insomnia than for individuals not experiencing insomnia over a 6-month period. In the
United Kingdom, the estimated yearly cost of absenteeism related to insomnia symptoms
has been identified to be $86.24 greater per employee with insomnia per year, than per
employee without insomnia. Furthermore, an estimated $260.97 has gone to salary
replacement. Salary replacement is the price of reimbursing an employee for his or her
sick leave when he or she is a salaried professional. Furthermore, up to $1,189.48 per
sleep-deprived employee has been attributed to loss of productivity over the course of a
year (Godet-Cayré et al., 2006). Nevertheless, missing work is not the only negative
consequence of insomnia. Being tired on the job also results in a number of negative
consequences. For instance, individuals who report symptoms of insomnia are more
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likely to report workplace errors, difficulty concentrating, decreased productivity, and
increased frequency of work-related accidents (Léger et al., 2002).
Insomnia also impacts the cost of medical care, which includes medical
consultation, transportation to consultations, prescription medications, over-the-counter
sleep products, and alcohol used to get to sleep (Daley, Morin, LeBlanc, Grégoire, &
Savard , 2009). The estimated total of all of these different insomnia-related costs is 6.6
billion dollars annually in Canada (Daley et al., 2009). As an example, when broken
down by category, the estimated cost of insomnia in Quebec alone is 191.2 million
Canadian dollars for transportation, 36.6 million for consultation, 16.5 million for
prescription medication, 18 million for over-the-counter sleep aids, and 339.8 million for
alcohol used to help with sleep (Daley et al., 2009).
Costs aside, how and why individuals develop symptoms of insomnia may be as
diverse as the presentation of insomnia symptoms. For instance, substances may impact
physiology and increase insomnia symptoms.
Substance use disorders. Alcohol, tobacco, and caffeine impair one’s ability to
sleep. Adult populations with co-occurring alcohol dependence have higher rates of
insomnia than individuals who are not dependent upon alcohol (Brower, 2015). Brower,
Krentzman, and Elizabeth (2011) found that the frequency of alcohol consumption over a
6-month period significantly predicted the presence of insomnia symptoms, and that
participants who abstained from alcohol or reduced alcohol to moderate levels achieved
the largest reduction in insomnia symptoms when compared to individuals who did not
reduce or abstain from alcohol.
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Related to adult alcohol intake, specific behaviors increase the risk of insomnia.
Adults who engage in binge drinking behaviors have increased chances of developing
insomnia, with individuals who binge drink more than two days per week having a 64%
greater chance of developing insomnia symptoms (Canham, Kaufmann, Mauro, Mojtabai,
& Spira, 2015). Popovici and French (2013) found that the rate of insomnia in the form
of trouble falling asleep among frequent alcohol users was 13% higher in women who
binge drink and 10% higher in men. Both men and women who engaged in binge
drinking behaviors reported higher rates of difficulty staying asleep, with women having
10% higher rates of trouble staying asleep than women who did not binge drink and men
having 8% (Popovici & French, 2013).
Alcohol, tobacco, and caffeine are also associated with increased rates of
insomnia symptoms in male adolescents ages 11 to 17 (Skarupke et al., 2015).
Adolescent girls who frequently drink coffee and drink alcohol are also more likely to
report symptoms of insomnia than girls who do not consume these substances (Skarupke
et al., 2015). Similar findings related to caffeine consumption increasing the likelihood
of insomnia have also been found in adults (Bonnet & Arand, 1992). Although the
correlation between daily habits and sleep are fairly clear, other predisposing variables
are less observable.
Genetics
Researchers continue to explore the heritability of insomnia. Palagini, Biber, and
Riemann (2013) found that insomnia might be inherited, as reflected in self-report ratings
from both family studies and twin studies. Insomnia is more common in individuals who
have first-degree blood relatives who also have insomnia than in individuals who do not
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have first-degree blood relatives with insomnia. Bastien and Morin (2000) reported that
35% of individuals who had family members who experienced insomnia also reported
experiencing insomnia. Of these participants, 76% reported that their mothers also
experienced insomnia. The rates of insomnia in biological relatives differ in clinical
versus nonclinical populations. In both groups, however, individuals who have firstdegree relatives with insomnia are more likely themselves to experience insomnia. In
clinical populations, 43.3% of individuals reported having first-degree relatives with
insomnia. The most frequently reported family member to also have insomnia was the
mother (Dauvilliers et al., 2005). Research shows significantly higher rates of heritability
in monozygotic twins than in dizygotic twins, with the likelihood of inheriting insomnia
being between 34% and 45% in monozygotic twins (Hublin, Partinen, Koskenvuvo, &
Kaprio, 2011). The studies referenced suggest that insomnia is highly dependent upon a
genetic predisposition. Genetics can be said to relate to the natural unfolding of
processes in the human body. In addition to genetics, aging should also be considered
when discussing naturally occurring processes. Aging and the normal biological
functions associated with aging have been shown to increase the chances of developing
insomnia (Reeve & Bailes, 2010).
Aging
As age increases, middle-of-night awakenings increase, sleep becomes shallower,
and variance in sleep phases increase during the night (Nau, McCrae, Cook, & Lichstein,
2005). Kim et al. (2013) found that the symptoms of insomnia differed as chronological
age increased. Older individuals with insomnia have greater difficulty initiating sleep,
have more early-morning awakenings, and have more difficulty maintaining sleep than

EVIDENCE BASED CBT-I

26

do middle-aged individuals (Kim et al., 2013). Although the objective measurements of
sleep duration and sleep quality show that rates of insomnia increase with age, subjective
reports indicate that insomnia is most reported between 18 to 24 years of age, increases
again at 45 to 54 years of age, and subjectively declines into old age (Grandner et al.,
2012). Objective increases in insomnia symptoms are attributable to a variety of causes.
For example, Cribbet et al. (2014) determined that individuals with shorter telomere
length (TL), which is an indication of cellular aging, reported higher rates of insomnia.
This information shows that insomnia may be a natural result of decreased physical
health. Conversely, Cribbet et al. also hypothesized that telomere damage may result
from sleep deprivation. Increased physical pain, common with aging, may also be
responsible for insomnia (Dzierzewski et al., 2010). Nocturia, or frequent urination, also
impacts the amount and quality of sleep in older adults (Zeitzer, Bliwise, Hernadnez,
Friedman, & Yesavage, 2013). Consequently, increased cellular aging, increased
physical pain, and other naturally occurring processes attributable to aging have a
negative impact on sleep. Other diagnoses also increase in prevalence with age, some of
which are neurological disorders.
Neurological Disorders
Although an exhaustive review of the neurological conditions that can impact
sleep is beyond the scope of this work, below are two conditions to serve as examples of
neurological conditions that may impact sleep. Insomnia is more prevalent in individuals
with certain neurological disorders than in individuals without such conditions. Specific
disorders may influence sleep mechanisms in different ways. For instance, individuals
diagnosed with Parkinson’s disease (PD) are more likely to experience insomnia than
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individuals without PD. PD interferes with sleep maintenance and consolidation but does
not appear to impact sleep onset (Pietro-Luca et al., 2015). The impact of PD on sleep
may be moderated partially by age, with individuals experiencing early-onset PD, aged
21 to 40 years, showing lower rates of insomnia than individuals with later-onset PD,
aged older than 40 years (Mahale, Yadav, & Pal, 2015).
Additionally, individuals with traumatic brain injuries (TBIs) commonly
experience dysregulation in their sleep-wake cycles. Individuals with more severe TBIs
report higher rates of insomnia. Localization of the TBI is also important because of the
functionality of different brain loci. Specifically, individuals with cerebral contusions
report high rates of insomnia (Jain, Mittal, Sharma, Sharma, & Gupta, 2014). Animal
experiments that intentionally manipulated the damage to various loci demonstrated the
impact that brain damage and TBI can have on sleep. TBIs in mice illustrate that
circadian rhythms are impacted by damage to the brain, delta wave activity is increased
during wakefulness, and genes that influence sleep in the cerebral cortex are affected
(Sabir et al., 2015).
The Importance of Assessment in CBT-I
Assessment is an integral part of CBT-I, generally conceptualized as occurring in
two forms. One form is retrospective assessment, which measures past behaviors and
symptoms that took place prior to the initial assessment and intake. The second type of
assessment is prospective, which measures ongoing symptom severity and takes place
throughout the assessment process (Perlis, Smith, Junquist, & Posner, 2008).
Because the present study intended to examine knowledge and practice density
related to CBT-I, it is reasonable to ascertain whether the sample employed essential
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assessment measures. The Epworth Sleepiness Scale (ESS) is one such widely-accepted
measure. The ESS quantifies daytime sleepiness and is considered generally to be an
accurate measure of the impact of insomnia and other conditions on daytime sleepiness
(Sanford et al., 2006). Research shows that the ESS is able to measure a continuum of
sleepiness (Sanford et al., 2006).
The ESS has been shown to have a high internal consistency (Miletin & Hanly,
2003), and it has also been shown to be valid and reliable with older adults from various
ethnic demographics (Beaudreau et al., 2010). A literature review failed to find research
examining how CBT-I practitioners use this measure to assess both the effectiveness of
their therapeutic interventions and alert them to potentially hazardous sleepiness, such as
while driving, operating machinery, or in other dangerous situations. By including this
variable in the study, the investigators can more accurately assess the potential
differences in how clinicians’ training and levels of education may impact their
utilization of this crucial, available assessment measure and their levels of adherence to
the standardized protocol of CBT-I.
Evidence-Based Insomnia Interventions
Evidence based practice (EBP) and empirically supported treatments (ESTs) are
necessary in providing patients with the most efficacious and effective care. EBP and
ESTs rely on the latest clinical research and professional expertise. Psychologists and
medical professionals are taught about EBP practice while in training so that their
ongoing practices can reflect the most effective forms of patient care with the highest
chance of success in reducing unwanted symptoms (Collins, Leffingwell, & Belar, 2007).
Pharmacological interventions are one such EBP.
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Psychopharmacological interventions. Prescription drugs are an effective
method used to attain nearly immediate, salubrious changes in sleep patterns.
Medications that are prescribed commonly to treat insomnia are referred to as sedatives
and hypnotics. Benzodiazepines, such as Valium, are an example of a medication that
induces sleep. In addition, medications that increase the availability of gammaaminobutyric acid (GABA) in the human brain are prescribed (Kryger et al., 2011). The
impact of more GABA in the human body is muscle relaxation, reduced anxiety, and
sedation. Medications such as zopiclone, zolpidem, and zaleplon, commonly referred to
as the Z drugs, gradually increase the availability of GABA rather than fast-acting
medications, are viewed as less addictive, and, as such, are a more preferred method of
pharmacological intervention (Wilson & Nutt, 2014).
Although a medication may be effective in the short-term, many drugs have side
effects that can negatively impact an individual’s health or react with other medications
or alcohol (Wilson & Nutt, 2014). Moreover, case examples cite Z drugs as the
precipitant to sleep walking, sleep driving, sleep eating, and sleep sex (Laliberte, 2016).
Menzin, Lang, Levy, and Levy (2001) found that some types of medication used
commonly to treat insomnia increase the chances of motor vehicle accidents. The impact
of some types of sleep aids on alertness and coordination is not isolated to when a person
is on the medication, meaning that effects may linger (Booth et al., 2016; Menzin et al.,
2001).
If medications are effective, individuals may adopt beliefs and assumptions that
medication is necessary to achieve sleep, increasing the chances of dependence. One
study that explored the rate of dependency among individuals treated with hypnotics
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found that as many as 7.9% of individuals developed dependency (Murakoshi, Takaesu,
Komada, Ishikawa, & Inoue, 2015). Dependency may lead to long-term use and
subsequent chemical changes in the brain that make achieving sleep difficult or
impossible without the chemical agent that originally made the changes (Wilson & Nutt,
2014). Although there is evidence for the effectiveness of psychopharmacological
interventions, there are attendant risks to such treatment. Fortunately, there is also strong
evidence for the efficacy and effectiveness of both behavioral and cognitive-behavioral
interventions for insomnia.
Nonpharmacological treatments. Cognitive, behavioral, and combined
cognitive-behavioral therapies are categories of ESTs for insomnia. Common therapeutic
interventions are based off of the understanding that the mechanisms controlling sleep are
influenced by behavior, thoughts, and emotions. The interplay between thoughts,
behaviors, and emotions is susceptible to change through intentional manipulation and
targeted therapeutic interventions. Common therapeutic interventions that systematically
target maladaptive patterns of thoughts, behaviors, and emotions are relaxation therapy,
stimulus control therapy, sleep restriction therapy (SRT), and sleep hygiene education
(Sharma & Andrade, 2012). For the purpose of this research study, an emphasis will be
placed on sleep hygiene, stimulus control, sleep restriction, and CBT-I
Sleep hygiene. Although not an EBP in its own right, instruction in sleep hygiene
has come to be a mainstay of insomnia treatment and borrows elements of the EBPs
covered below. Sleep hygiene refers to a general set of lifestyle choices rather than a
strict and regimented behavioral intervention. For example, sleep hygiene suggests
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physical exercise that is timed to facilitate both general health and sleep. Specifically,
exercise is endorsed, but generally not in close proximity to bedtime (Horne, 2014).
Other aspects of sleep hygiene include recommendations about the amount and
timing of alcohol consumption, dietary awareness regarding sugar intake and caffeine
consumption, proscription of napping, and awareness of environmental stimuli, such as
noise and lighting (Horne, 2014).
Sleep hygiene recommends that individuals abstain from or dramatically limit
alcohol because alcohol interferes with sleep. For example, the consumption of alcohol
reduces the likelihood of rapid eye movement (REM) sleep, which is an important
component of restorative sleep. Additionally, naps are not recommended because they
may interfere with naturally occurring circadian rhythms and do not allow for the
accumulation of sleep debt. To date, no known outcome studies address the efficacy of
sleep hygiene.
Stimulus control. Stimulus control is an empirically proven therapeutic
intervention for insomnia and can be used to control an organism’s response to stimuli in
the environment. An organism is said to exhibit stimulus discrimination if it responds
differently to two or more stimuli (Domjan, 2010). As it pertains to sleep, a
discriminative stimulus is relevant when “cues associated with falling asleep are
separated from activities incompatible with sleeping” (Zwart & Lisman, 1979, p. 113).
The process of learning and pairing stimuli in the environment with the biological
rhythms of the human body (covert responses) is made possible by timing of specific
overt behavioral responses. The behavioral interventions include lying down to sleep
only when sleepy, getting out of bed if one is unable to fall asleep after 10 to 20 minutes,
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reserving the bed only for sleep and sexual activities, and getting out of bed at the same
time every day as prompted by an alarm (Bootzin, 1973; Bootzin & Rider, 1997). When
applied consistently, the use of stimulus control may reduce symptoms of insomnia
(Zwart & Lisman, 1979). Puder et al. (1983) demonstrated that stimulus control is
particularly useful for reducing sleep latency, which is the time an individual requires to
fall asleep after getting into bed. Individuals who employ the use of stimulus control for
treating their insomnia symptoms may experience decreased sleep latency by as much as
50% (Puder, Lacks, Bertelson, & Storandt, 1983).
Other areas of research have focused on the effectiveness of stimulus control
when compared with medication. Results show that medication and stimulus control are
both useful for reducing an individual’s insomnia. Nevertheless, there are some notable
differences between the two. For example, the reductions in insomnia achieved through
pharmacology do not persist after medication cessation. In contrast, the reductions in
unwanted insomnia symptoms are maintained longer when stimulus control is employed
in comparison to medication alone. Symptom reduction includes improvements in total
sleep time, sleep efficiency, and sleep quality (Riedel et al., 1998).
Sleep restriction. Sleep restriction is an EBP that is used to normalize sleep
patterns (Perlis et al., 2008). The amount of time an individual spends in bed is an
important contributor to the variance in sleep and wakefulness. Sleep restriction
functions by reducing the amount of sleep time in bed initially, followed by allowing
sleep for an extended period of time in bed once sleep efficiency has improved (Spielman
et al., 1987). The adjustment in sleep times and time spent in bed results in a decrease in
the amount of time before falling asleep.
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Sleep efficiency is assessed using a sleep diary data and the efficiency of one’s
sleep is measured weekly. Sleep efficiency is calculated by dividing the time a person
goes to bed by the total hours her or she spends in bed multiplied by 100. The equation
yields a reliable source of measuring sleep continuity. Sleep continuity refers to how
well someone is sleeping. Upward titration of time spent in bed is done when a person
achieves 90% sleep efficiency for a full week. Downward titration occurs when sleep
efficiency is less than 85% (Perlis et al., 2008). This intervention recommends that
daytime naps be avoided while more regimented wake time and sleep time are imposed.
By adhering to this structure, the individual returns to an appropriate, endogenous sleepwake pattern. The logic associated with this intervention is that it increases sleep debt
(Falloon, Elley, Fernando, Lee, & Arroll, 2015).
SRT for the treatment of insomnia is effective in both inpatient and outpatient
settings. Although the literature pertaining to inpatient treatment of insomnia with sleep
restriction is limited with regard to inpatient psychiatric care, Morin, Kowatch, and
O’Shanick (1990) demonstrated that it could be used to treat insomnia effectively in this
setting. Morin et al.’s research demonstrated that reducing the amount of time spent in
bed initially and allowing for more time in bed once asleep increased sleep duration from
2.5 to 6 hours per night in an individual with co-occurring insomnia and depression. The
improved sleep time endured immediately following the patient’s discharge and 4 months
after the discharge. In an outpatient setting, stimulus control has been shown to increase
sleep efficiency by 13%, with improvements up to 20% when sleep restriction is used in
combination with increased physical activity (Wang, Yin, Li, Liang, & Wei, 2015).
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Research demonstrates that simplified sleep restriction therapy is an effective
intervention for reducing symptoms of insomnia in individuals with primary insomnia
(Falloon et al., 2015). SRT has been shown to decrease insomnia symptoms within 3
weeks. Improvements include a decrease in sleepiness/fatigue and negative mood (Miller,
Kyle, Marshall, & Espie, 2013).
Cognitive-Behavioral Therapy for Insomnia
CBT-I is an empirically validated treatment for insomnia that utilizes elements of
stimulus control, sleep hygiene, and sleep restriction. In addition, CBT-I addresses
dysfunctional thought patterns and behaviors that may contribute to symptoms of
insomnia. These combined therapeutic interventions change an individual’s cognitions
regarding sleep and insomnia while simultaneously modifying maladaptive patterns of
behavior, with the goal of promoting restorative sleep (Eidelman et al., 2016; Perlis et al.,
2008). There is evidence that modifying dysfunctional beliefs about sleep can decrease
symptoms of insomnia and improve outcomes for the behavioral interventions. Followup studies indicate that these results are maintained for at least 6 to 12 months after
cessation of the therapeutic intervention (Eidelman et al., 2016). Even brief CBT-I
workshops that last only 1 full day are highly effective in reducing symptoms of insomnia
(Swift et al., 2012).
CBT-I has also been shown to be effective in treating comorbid disorders that are
exacerbated by irregular sleep patterns. For example, CBT-I has been shown to reduce
hypomania/mania in individuals with bipolar disorder by improving and normalizing
sleep patterns (Harvey, Gehrman, et al., 2014). CBT-I is also highly effective in treating
comorbid insomnia and insomnia associated with arthritis and coronary artery disease
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(Rybarczyk, Mack, Harris, & Stepanski, 2011). Although CBT-I and each of the
component pieces that comprise CBT-I have been shown to be efficacious, factors such
as timing and the type of the therapeutic interventions employed may impact the amount
of improvement to an individual’s sleep.
Efficacy of CBT-I. When assessing long-term symptom remission, CBT-I has
been proven to be a more efficacious therapeutic treatment modality for reducing
symptoms of insomnia when compared to medication alone. Specifically, CBT-I is
superior to benzodiazepines and non-benzodiazepine that include zopiclone, zolpidem,
temazepam, and triazolam. There are mixed findings when comparing medication and
CBT-I for short-term symptom reduction, with some evidence suggesting that medication
is superior in the short-term and other evidence suggesting that CBT-I is superior
(Mitchell, Gehrman, Perlis, & Umscheid, 2012). When compared to behavior therapy
(BT) or cognitive therapy (CT) alone, CBT-I shows high treatment response rates, with
rates as high as 67.4% and 67.3% showing positive responses in BT and CBT conditions,
respectively (Harvey, Gehrman et al., 2014). Although the percentages between BT and
CBT may be similar, individuals who receive CBT-I interventions retain better symptom
remission rates for longer periods of time than CT or BT alone, according to follow-up
data (Harvey, Gehrman, et al., 2014). The enduring benefits of CBT-I make the
treatment a justifiable therapeutic intervention for insomnia.
Alternative methods of delivery for CBT-I have been proposed based on the
success of individual CBT-I interventions and the limited availability of practitioners
who are adequately trained to provide empirically supported interventions for insomnia
(Koffel, Koffel, & Gehrman, 2015). One alternative delivery method for CBT-I is group
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therapy (Koffel & Farrell-Carnahan, 2014; Koffel et al., 2015; Yamadera et al., 2013).
Although group CBT-I has been shown to be efficacious (Koffel et al., 2015), other
research suggests that individual CBT-I is more effective than group CBT-I (Yamadera et
al., 2013). Yamadera et al. (2013) found that greater improvements occur in the areas of
sleep onset latency, objective sleep efficacy, and overall sleep quality in individual CBT-I
when compared to group CBT-I.
Other research compared group CBT-I to Internet-delivered CBT-I in an effort to
increase the availability and dissemination of empirically based interventions for
insomnia (Seyffert et al., 2016; Zachariae, Lyby, Ritterband, & O’Toole, 2016).
Proponents of Internet-delivered CBT-I suggest that it is cost effective and easily
accessible. Additional strengths of Internet-delivered CBT-I are that it could save time
and be less intimidating than in person therapy (Voinescu, Szentagotai, & David, 2013).
Weaknesses include the necessity for a computer and Internet access, lack of face-to-face
contact, an inability to manage crises, and a general lack of data regarding effectiveness
of Internet-delivered CBT-I for individuals with comorbidities (Voinescu et al., 2013).
De Bruin, Oort, Bögels, and Meijer (2014) found group CBT-I and Internet-delivered
CBT-I to be equally efficacious, showing significant improvements occurring with
medium-to-large effect size for sleep onset latency, wake after sleep onset, and sleep
efficiency. Internet-delivered CBT-I can be an effective treatment for adults and can
significantly improve insomnia severity, sleep efficiency, subjective sleep quality, wake
after sleep onset, sleep onset latency, total sleep time, and the number of nocturnal
awakenings (Zachariae et al., 2016). Although CBT-I is a durable therapeutic modality
and effectively reduces insomnia in a variety of ways, it appears to reduce symptoms
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differently from medication alone. By influencing the natural mechanisms of sleep
through behavioral and cognitive interventions, the biology that underlies sleep is
changed to promote consistent and restorative sleep.
Timing and Effectiveness of Therapeutic Interventions for Insomnia
The rate at which gains are achieved by medication is different from the rate of
symptom reduction attained by behavioral interventions. Another notable difference is in
the relapse rate after treatment cessation. One study that focused on relapse rate for
insomnia compared triazolam with behavioral interventions for insomnia. Results
showed that symptom reduction occurred more quickly with medication, but symptoms
returned to baseline after medication cessation. In contrast, the behavioral interventions
took longer to reduce symptoms—as long as 2 weeks—but were maintained for longer
periods of time after formal treatment (McClusky et al., 1991). One should note that
behavioral interventions for insomnia require monitoring baseline symptoms and
providing psychoeducation that explains the purpose of the therapeutic interventions.
Both of the aforementioned elements of treatment could be contributing factors for why
symptom reduction takes 2 weeks. Subsequent research has shown that the combination
of medication and behavioral interventions produces better outcomes than medication or
BT alone (Milby et al., 1993). Further evidence supporting the combined benefits of
pharmacotherapy and relaxation or behavioral interventions was demonstrated by Rosen,
Lewin, Goldberg, and Woofolk (2000). Researchers demonstrated similar findings to
those of Milby and colleagues (1993), showing that the benefits could be measured
differentially between behavioral interventions and pharmacotherapy combined versus
BT alone. Results showed that pharmacotherapy and relaxation yielded improvements in
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total sleep time, sleep efficiency, and wakefulness after sleep onset, whereas relaxation
alone yielded improvement in only total sleep time (Rosen et al., 2000).
Objective improvements in sleep duration are influenced by the sequence with
which medication and CBT-I are applied. Further, it is important to note is that the point
in therapy during which participants experienced a reduction in symptoms relative to the
therapeutic intervention differed. Results demonstrated that both CBT-I and
pharmacological interventions decreased symptoms of insomnia, with a particular
advantage for an overlap of medication and CBT-I. Research also showed that when
medication and CBT-I were introduced early in treatment, improvements occurred more
rapidly than when pharmacological interventions were introduced first, followed by
cognitive-behavioral interventions. Thus, these findings imply that the timing and type of
intervention selected by practitioners may impact the rate with which the individual
experiences symptom relief. The selection of appropriate interventions may depend on a
series of variables, including knowledge of relevant therapeutic interventions (Campbell
et al., 2013), diagnostic accuracy (Jensen-Doss & Weisz, 2008), and level of training
(Spengler & Pilipis, 2015).
Level of Training, Appropriate Diagnosis, and Treatment Planning
Research regarding the training of mental health providers has shown that the rate
at which doctoral level psychology students received education on appropriate diagnosis
and treatment planning regarding sleep disturbance was 32% in 1993. The same study
found 58% of students studying family practice, 65% studying pediatrics, and 87%
studying neurology in medical school were receiving education on sleep. Psychology
was the second most infrequent of all the professional fields to receive sleep education,
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second to the nursing profession, with a reported 19% of nursing programs in 1993
including education on sleep disorders and therapeutic interventions for sleep (Moline &
Zendell, 1993).
In 1998, all American Psychological Association-accredited clinical psychology
programs were surveyed regarding the extent to which sleep medicine was part of
program development. Of 184 programs, a total of 132 schools responded. Responses
showed that 81% of American Psychological Association-accredited schools had no
training, 14% had minimal training, and 5% had systematic training available (Lichstein
et al., 1998). More recent literature shows relatively little improvement in the education
of psychology students. By 2009, 6% of psychology training programs offered formal
didactic courses in sleep and 31% of training programs offered education on treating
sleep disorders. Overall, training programs are understaffed in regard to professionals
knowledgeable about sleep disorders, with 16% of the programs polled reporting that
they have faculty trained in sleep medicine (Meltzer et al., 2009). Although sleep-related
training for psychology students is limited, approximately 39% of training directors
believe it should be a mandatory part of the curriculum (Meltzer et al., 2009). It should
be noted that 53% of student participants found their programs’ education on sleep,
cognition’s role in sleep, and sleep-related disorders to be effective, but 13% of those
who reported their programs’ sleep-related education was effective also reported that they
felt incompetent to treat sleep disorders. This disparity is important to note because
although students received education on sleep disorders, many felt unable to deliver
treatment competently, thus implying a deficit between didactic knowledge and training
and the ability to competently and confidently apply empirically based interventions for
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insomnia. Research shows that even brief training can increase a practitioner’s ability to
assess the role of sleep in mental and physical health care and to apply therapeutic
interventions for sleep disorders (Peachey & Zelman, 2012); however, the research
pertaining to the application and competency of mental health practitioners’ application
of CBT-I is extremely limited.
Accurate diagnosis is an important part of selecting appropriate interventions and
can increase the impact of selected interventions (Jensen-Doss & Weisz, 2008). The
accuracy of a diagnosis and accurate selection of treatment areas are not significantly
influenced by years of experience (Spengler & Pilipis, 2015). With that said, research
shows that therapists with graduate degrees have significantly higher rates of global
performance fidelity ratings and significantly higher adherence than individuals with
bachelor’s degrees (Campbell et al., 2013). Performance fidelity describes adherence to
manualized treatment. Campbell et al. (2013) examined how clinicians’ level of training
impacted the treatment of drugs and alcohol. A performance fidelity rating system was
composed of adherence delivery of specific treatment content, competence and skill,
global empathy, behaviors that detract from general therapist skill and should not occur,
and overall session performance (Campbell et al., 2013). An example of behaviors that
should not occur during therapy is excessive self-disclosure. The results suggest that
increased experience, operationalized as graduate degrees and above, related directly to
more linear and more effective treatment. Data from a meta-analysis that explored the
impact of therapists’ training, experience, and therapy outcomes indicated that therapists
with more training are less likely to have clients drop out of treatment in an outpatient
setting (Stein & Lambert, 1995). To date, little research has examined the area of sleep
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medicine and how training is provided. The research regarding how experience impacts
the application of CBT is mixed. Evidence shows that more training in CBT increases a
therapist’s efficacy, but some research also states the opposite.
Level of training and the impact on CBT interventions. CBT-I practitioners
and the broader subfield of sleep disorder researchers have long been interested in how to
make training optimally efficient and effective. Variables of interest include level of
education (e.g., practicum students, interns, and licensed professionals), the participant’s
level of education as measured by his or her year in a graduate program, the impact of
supervision on CBT application, and client satisfaction in the form of outcome measures
and reduction in unwanted symptomatology. The results show mixed findings on
whether and how training and experience impact practitioner knowledge and competency
when applying CBT to various disorders (Norton, Little, & Wetterneck, 2014; Nyman,
Nafziger, & Smith, 2010). CBT is referenced rather than CBT-I because the literature
related to a clinician’s level of training is minimal. The researchers in the present study
used the most relevant body of literature in order to show that there is a correlation
between a clinician’s therapeutic effectiveness and skill, and how they relate to the
clinician’s level of training and profession.
Research appears to support a difference in therapists’ abilities to provide CBT
interventions based on their years of experience and knowledge. In a study designed to
assess the effectiveness of practitioners in training, researchers found that the trainees
were effective but that their effectiveness was generally less than that of the comparison
groups of practitioners. Groups, including doctoral externs, interns, and postdoctoral
fellows, were compared according to their levels of training when treating major
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depression, dysthymia (persisting depressive disorder), bipolar disorder I and II, mood
disorder not otherwise specified (NOS), depressive disorder NOS, generalized anxiety
disorder, agoraphobia, and obsessive-compulsive disorder (APA, 2000/2013). The
improvements in symptoms were assessed using the Beck Depression Inventory and the
Beck Anxiety Inventory. The results suggested that trainees may be effective but were
less effective than their more experienced peers. The results indicated that there was a
difference in clinician training and respective ability to treat symptoms with CBT (Forand
et al., 2011). Another relevant study compared CBT competence and experience relative
to a mental health practitioner’s professional degree. The study compared clinicians’
CBT skills before and after a 5-hour workshop in CBT skills. The study found a
significant difference between professional degrees groups. Psychologists performed
better than nurses and psychiatrists on all CBT-related measures. The CBT measures
included supervisor rating and grades awarded on written assignments. The
measurements pertained to case conceptualizations and how clinicians would treat
presenting symptoms. Older individuals in this study performed significantly worse on
training outcomes when compared to younger individuals (McManus, Westbrook,
Vazques-Montes, Fennell, & Kennerley, 2010). Another study found that experienced
CBT therapists had statistically higher patient improvement in regard to their symptom
reduction, whereas less experienced practitioners had higher rates of deterioration than
could be expected by chance alone (Branson, Shafran, & Myles, 2015). Huppert et al.
(2001) also found that experience, in the form of number of years in the field, influenced
outcome.
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In contrast, Nyman et al. (2010) examined differences in practitioners’ skills as
they related to the application of CBT and found no differentiation among different levels
of therapists when comparing application of CBT for anxiety, depression, suicidal
ideation, self-esteem, and interpersonal conflict. When the different groups of
practitioners were compared (i.e., practicum students, interns, and licensed practitioners),
there were no significant differences between the three levels of education and the
corresponding amount of symptom reduction among groups (Nyman et al., 2010). The
study listed a variety of limitations that could have confounded the results and that may
limit its generalizability. Specifically, the study did not describe the method of delivery
for the cognitive-behavioral interventions, such as manualized versus non-manualized
treatment. Distinguishing interventions is important because without a similar or
identical treatment intervention, determining whether the clinician’s skill, the type of
intervention, or the experience is responsible for differences found is difficult.
In another study, Norton, Little, and Wetterneck (2014) found that patients who
attended group-led CBT for anxiety disorders experienced equal amounts of symptom
reduction in “senior therapists” and “junior therapists” group conditions. Researchers
differentiated senior therapists’ mean years of experience to 2.89 years and the average
junior therapists’ mean years of experience to 2.19 years. This difference in range of
experience was small and could limit the effects of experience on the overall practitioner
differences.
Influence of Practitioner Education and Training on Application of CBT-I
To date, only one study, conducted by the Department of Veteran Affairs (VA),
has examined how CBT-I is taught to and applied by mental health and medical
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practitioners. The participants were six cohorts of practitioners who were taught CBT-I
using the VA CBT-I training program. The first six cohorts consisted of 135
psychologists, 50 clinical social workers, 11 nurses, 10 psychiatrists, and 1 individual
who did not indicate his or her profession. The purpose of the study was to assess the
VA’s training methods and the clinicians’ perceptions of self-efficacy delivering CBT-I,
as well as their attitudes about delivering CBT-I (Manber et al., 2013). The VA study is
directly applicable to the present study because it explored subjective attitudes toward
applying CBT-I based on specific aspects of training, in this case the VA CBT-I training
program. The study’s demographics divided the cohort of practitioners into their
respective professions. The professions were not compared in this study, but the present
study intended to explore how a difference in professions and education levels may
impact attitudes and knowledge about CBT-I. Of the practitioners assessed in the
Manber et al. (2013) study, 74% had provided CBT-I within one month prior to the study.
Results showed that practitioners who received formal training in CBT-I reported higher
ratings of skill-specific self-efficacy and increased positive attitudes toward CBT-I than
individuals who did not receive training (Manber et al., 2013). The results showed that
the type of education and training impacts clinicians’ attitudes and their perceived ability
to apply CBT-I interventions. Similar to the VA study’s objectives, the present study
intended to explore how a difference in profession and education level may impact
attitudes and practice related to CBT-I.
Internet-Based Questionnaires
Questionnaires are a commonly used method to obtain both subjective and
objective information for the purpose of analysis. The present study utilized a one-time
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web-based questionnaire. Research shows that, in most cases, web-based surveys
achieve the same or very similar results as pen-and-paper questionnaires (De Beuckelaer
& Lievens, 2009; Van de Looij-Jansen & Jan de Wilde, 2008). Van de Looiji-Jensen and
Jan de Wilde (2008) referenced notable areas that are commonly thought to differ
between web-based and pen-and-paper questionnaires. Some of the topics that a
participant may feel less inclined to disclose in pen-and-paper questionnaires include
alcohol use, marijuana use, vandalism, and stealing. Results from the experiment showed
that there was one area that adolescents reported less frequently when completing penand-paper questionnaires: Adolescents show a difference in the frequency with which
they report carrying a weapon, with more adolescents reporting carrying a weapon in
web-based surveys than with pen-and-paper. These findings suggest that participants
may feel more inclined to disclose information on web-based questionnaires.
Smith, King, Butow, and Oler (2013) also found advantages for web-based
questionnaires, in that they were returned quicker and required fewer reminders than penand-paper questionnaires. The same study also found that more highly educated
individuals favored the web-based questionnaires than the pen-and-paper questionnaires,
which is particularly relevant for the present study because all participants had advanced
degrees.
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Chapter 3: Hypotheses

Research Question 1
Does specialized CBT-I training history predict reported adherence to the use of EBP?
Hypothesis 1. It was hypothesized that level of CBT-I training history would be
a significant and positive predictor of reported adherence to the use of EBP. Training
history was defined operationally as reported number of hours of CBT-I training (i.e.,
dedicated training time during graduate school, internship, or post-doctoral fellowship;
continuing education units; and hours receiving supervision). For the purposes of this
study, EBP was defined as a participant’s percentage of accurate answers on a
questionnaire that focuses specifically on common elements of CBT-I, and was based on
the empirically derived protocols of Perlis, Manber, Morin, and Edinger (Edinger &
Carney, 2015; Manber & Carney, 2015; Morin & Espie, 2003; Perlis et al., 2008).
Research Question 2
Does CBT-I training history predict reported practice density in CBT-I?
Hypothesis 2. It was hypothesized that CBT-I training history would be a
significant and positive predictor of reported practice density. Training history was
defined operationally in terms of number of hours of CBT-I training (i.e., dedicated
training time during graduate school, internship, or post-doctoral fellowship; continuing
education units; and hours receiving supervision). Practice density was defined
operationally in terms of the number of years of CBT-I practice and percent of practice
that is devoted to CBT-I.
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Research Question 3
Do the various disciplines that conduct CBT-I differ with respect to CBT-I education,
CBT-I training, practice density, and/or adherence to the use of EBP?
Hypothesis 3. It was hypothesized that there would be no group difference with
respect CBT-I training, reported practice density, and/or reported adherence to the use of
EBP. Practice density was defined operationally as the reported number of hours in the
past year that a practitioner treated insomnia. Discipline was defined operationally by the
therapist’s professional license (i.e., BA, BS, MA, MS, RN, MSN, MSW, LCSW, NP,
Psy.D., Ph.D., Do, MD, RST, Other).
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Chapter 4: Method

Research Design
The study used a correlational research design to explore the relationship between
a therapist’s level of education, experience, application preferences for CBT-I, and
knowledge of evidence-based CBT-I practice.
Participants
A total of 233 respondents began the questionnaire and 165 were included in the
final analyses. The participants in this study consisted of mental health and medical
practitioners who were trained in CBT-I. Combined, the practitioners were from 10
different countries. The countries of residence included the United States, Canada,
Australia, Thailand, Brazil, New Zealand, England, Denmark, Italy, and Taiwan. The
majority of participants were from the United States, making up 86.6% of the sample
(143 participants). There were eight participants from Canada, seven from Australia, two
from New Zealand, one from the United Kingdom, one from Brazil, one from Denmark,
one from Italy, and one from Taiwan. The sample consisted mostly of Caucasian
individuals (92.1%; 152 participants). Other races represented in the sample included
Black (one participant), Asian (five participants), Latino (three participants), and MultiRacial (four participants). The sample was 73% female, and the mean age of all
participants was 47 years with a range of 28 to 82 years.
Inclusion criteria. In order to participate in this study, a person had to be
considered a professional of who was trained in CBT-I, who had earned an academic
degrees and had some level of training, though degree and training levels varied among
participants. In order to ensure inclusion criteria was met, participants were recruited
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from three separate CBT-I specialty listservs, including (BSMG-L; n ≈ 500), CBT-I
Seminar Survivors (n ≈ 400), and the University of Pennsylvania Provider Directory (n ≈
1,000 [worldwide]).
Exclusion criteria. Individuals were excluded from the study if they were not
trained in CBT-I, did not hold academic degrees, or were not part of the listservs
mentioned previously. Practitioners were also excluded from analysis if their responses
were incomplete, because incomplete data misrepresented the variable or variables of
interest. Initial respondents who were excluded from this study are illustrated in Figure 1.
Figure 1
Consort Diagram of Attrition
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Measures
The researchers collaboratively developed a 56-item questionnaire based on the
variables of interest. All testing instruments used were the result of collaboration with
senior level recognized experts in field. The experts are doctoral level professors who
have peer-reviewed publications, regularly lead training seminars, provide clinical
practice in behavioral sleep medicine for insomnia, and conduct research at the
University of Pennsylvania and the Philadelphia College of Osteopathic Medicine.
The questionnaire followed the following format: basic demographic information,
information pertaining to education and training, behavioral sleep medicine practice
preferences, and behavioral sleep medicine practice knowledge/approaches (See
Appendix A).
Procedure
The current study was conducted using a one-time Internet-based questionnaire.
The survey was distributed to three listservs that were composed of practitioners who
have been trained in CBT-I. Permission was obtained from the listserv moderator to
contact all members of the Internet mailing list. All practitioners were invited to
participate voluntarily in the survey.
The Internet-based questionnaire was delivered through RedCap. The
information was collected as an Internet survey that was sent to mental health and
medical professionals who were known to be trained in or practicing evidence-based
CBT-I treatment. Data derived from the questionnaire included demographic practitioner
information, such as age, sex, country in which the professional practiced CBT-I, and the
practitioner’s ethnicity. The survey assessed the practitioner’s professional demographics,
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including his or her highest degree, type of professional license, number of years of
practice, and average number of hours seeing patients per week. Practice
approach/knowledge applying CBT-I were measured using questions that assessed the
type of format (i.e., individual, couples, groups); the setting, such as outpatient or
inpatient; the number of typical sessions; the ideal number of sessions; the frequency of
sessions; and the components of the CBT-I protocol that were used according to necessity
and importance.
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Chapter 5: Results

Table 1
Full Sample Training and Variables of Interest: Mean, Standard Deviation, and Range
________________________________________________________________________
Variable
M
SD
Range
Training Hours
671.90
1298.7
4 - 6600
Adherence %
64.7
22.7
4.3 - 95.6
Practice %
35.3
32.4
0 - 100
Years Practicing
7.6
6.5
0 - 27
Table 2
Group Comparison of Training and Variables of Interest: Mean, Standard Deviation,
and Range
________________________________________________________________________
Variable
M
SD
Range
Master’s Doctoral
Master’s Doctoral
Master’s Doctoral
Training Hours 304.8
821.2
833.2
1422.8
4-4020
6-6600
Adherence %
66.3
64.0
24.1
22.2
4.3-95.6 4.3-95.6
24.3
39.9
31.9
31.7
0-100
0-100
Practice %
Years Practicing 3.6
9.1
3.5
6.7
0-20
0-27
Linear regression was computed to test the first hypothesis, that the level of CBTI training history would be a significant and positive predictor of reported adherence to
the use of EBP (percentage of correct answers on the practice questionnaire).
Additionally, to test the second hypothesis, linear regressions were computed to
determine whether the total hours of advanced training in CBT-I predicted practice
density (total annual CBT-I practice out of total practice hours) and the total number of
years practicing CBT-I (lifetime total number of years practicing CBT-I). The intention
of assessing practice density and years practicing was to determine how training history
impacts the trajectory of professional development and the application of CBT-I among
various mental health disciplines.
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Finally, to test the third hypothesis, a series of t-tests examined group differences
in CBT-I training, reported practice density, and reported adherence to the use of EBPs
between master’s and doctoral level practitioners. Due to statistically significant group
differences between variables, specifically level of education, the sample as a whole was
divided into relevant subgroupings. Linear regression was used to determine whether the
total advanced training hours in CBT-I predicted adherence to empirically validated
treatment (percentage of correct answers on the practice questionnaire) for both master’s
and doctoral level practitioners. Additionally, linear regressions were computed to
determine whether the total hours of advanced training in CBT-I predict practice density
(total annual CBT-I practice out of total practice hours) and the total number of years
practicing CBT-I (lifetime total number of years practicing CBT-I) for both master’s and
doctoral level practitioners.
Statistical Analyses
The variables of interest were analyzed using JMP Statistical Software. A power
analysis was computed for the regression analyses to determine how many participants
were necessary. The effect size was set for medium effect size and the significance level
was set for .05. The power level was set at .80, as is standard in the social sciences. The
analyses determined that 85 participants were needed to perform regression analyses.
Demographic Analyses
The sample consisted of 165 participants, who were 73% female and 27% male.
Participants’ reported ethnicities included one Black, five Asian, 152 Caucasian, three
Latino, and four Multi- Racial. The age range of the participants was 25 to 82 years. The
mean age for the sample was 46.7 years and the standard deviation was 12.4 years.
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Hypothesis 1
To test whether CBT-I training history (number of hours of advanced training)
predicted adherence to EBP (percentage of correct answers on the CBT-I questionnaire),
a linear regression was conducted for the sample as a whole. The linear regression
revealed no significance with regard to total training hours predicting practice adherence
for the full sample, R2 = -.01, F(1,64) = .18, p < .67 (See Table 3).

Table 3
Training History and Adherence Regression Analysis (Whole Sample)
________________________________________________________________________
Model
Sum of
df
Mean Square
F
Sig
Squares
Regression
95742238
64
1495972
.1841
.67
M-Residual

275429

Total

96017667

1

275429

65

Next, to examine the surprising lack of significance, several post-hoc analyses
were conducted. First, linear regressions were used to assess whether CBT-I training
history predicted practice adherence by level of education, by splitting master's and
doctoral level participants into separate groups. The linear regressions revealed no
significant results with regard to training history predicting adherence for either doctoral
level practitioners, R2 = -.02, F(1,42) = .20, p < .69), or master’s level practitioners, R2 =
-.05, F(1,20) = .04, p < .82 (See Tables 4 and 5).
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Table 4
Training History and Adherence Regression Analysis (Masters Group)
________________________________________________________________________
Model
Sum of
df
Mean Square
F
Sig
Squares
Regression
23077034
20
153852
.05
.83
Residual
Total

55409
23132443

1

55409

21

Table 5
Training History and Adherence Regression Analysis (Doctoral Group)
________________________________________________________________________
Model
Sum of
df
Mean Square
F
Sig
Squares
Regression
71404904
42
700117
.20
.70
Residual
Total

273485

1

71678389

43

273485

A Pearson's chi-square item analysis was used to assess for statistically significant
differences between master’s and doctoral level practitioners. This comparison revealed
no significant differences with respect to individual items on the Pearson’s chi-square
with the statistical significance level set at .05 (See Table 6).
Of note were several items that both master’s and doctoral level practitioners
answered incorrectly more frequently than expected. Expected in this context refers to
error rates equal to or exceeding 50% incorrect. The 50% threshold is based on the
researchers’ qualitative comparisons of item scores rather than specific statistical practice.
The higher than expected error rate included item 31 (When conducting CBT-I, what
treatments do you typically use?), item 34 (How do you assess and determine prescribed
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time in bed [PTIB], i.e., prescribed sleep opportunity?), and item 42 (When conducting
sleep restriction, the rule I use for time to bed is_____.).
Item 31 assessed the practitioners’ use of the essential components of CBT-I
(sleep restriction, stimulus control, cognitive elements, and sleep hygiene). Results
indicated both master’s and doctoral level practitioners had a tendency to omit sleep
hygiene as a recommendation. Master’s level clinicians omitted sleep hygiene 60% of
the time and doctoral level practitioners omitted sleep hygiene 67.4% of the time. The
omission of this component of the CBT-I protocol resulted in a disproportionate error rate
when compared to the error rates of the other items.
Item 34 assessed the practitioners’ understanding of prescribed time in bed. The
percent of master’s level clinicians that answered the item incorrectly was 53.33% and
the doctoral level incorrect response rate was 66.70%. Item 42 assessed practitioners’
application and understanding of time to bed, which is a formula that is an important
component of CBT-I. Sixty percent of master’s level practitioners answered incorrectly
and 66.67% of doctoral level practitioners answered incorrectly.

Table 6
Chi-Square Item Analyses for Education and Practice Adherence
Item

Degree

N

% of Incorrect
% of Correct
Prob.
Responses
Responses
Item 31(a)
Masters
15
20.00
80.00
.97
Treatment 1
Doctorate
49
20.41
79.60
________________________________________________________________________
Item 31(b)
Master’s
15
20.00
80.00
.74
Treatment 2
Doctorate
49
16.33
83.70
________________________________________________________________________
Item 31(c)
Master’s
15
33.33
66.70
.60
Treatment 3
Doctorate
49
40.82
59.18
________________________________________________________________________
Item 31(d)
Master’s
15
60.00
40.00
.60
Treatment 4
Doctorate
49
67.40
32.65

EVIDENCE BASED CBT-I

57

________________________________________________________________________
Item 32
Master’s
16
37.50
62.50
.36
Essential
Doctorate
49
55.10
42.90
instruments
________________________________________________________________________
Item 33
Master’s
15
20.00
80.00
.66
Sleep eff.
Doctorate
47
25.53
74.50
calc.
________________________________________________________________________
Item 34
Master’s
15
53.33
46.70
.40
Assess (PTIB) Doctorate
48
66.70
33.33
________________________________________________________________________
Item 35
Master’s
14
7.14
92.90
.64
Days of
Doctorate
48
4.17
95.83
sleep diary
________________________________________________________________________
Item 36
Master’s
15
33.33
66.70
.64
Sleep eff.
Doctorate
48
27.08
72.92
& sleep diary
________________________________________________________________________
Item 37
Master’s
15
26.70
73.33
.53
Rule
Doctorate
48
35.42
64.60
upward titration
________________________________________________________________________
Item 38
Master’s
15
33.33
66.67
.30
Rule:
Doctorate
48
50.00
50.00
downward
titration
________________________________________________________________________
Item 39
Master’s
15
20.00
80.00
.13
No change
Doctorate
48
41.70
58.33
PTTB
________________________________________________________________________
Item 40
Master’s
15
53.33
46.70
.10
Upward
Doctorate
49
30.61
69.40
titration PTTB
________________________________________________________________________
Item 41
Master’s
15
13.33
86.70
.80
CBT-I
Doctorate
48
10.42
89.60
frequency
________________________________________________________________________
Item 42
Master’s
15
60.00
40.00
.64
Time to
Doctorate
48
66.70
33.3
bed rule
________________________________________________________________________
Item 43
Master’s
16
12.50
87.50
.98
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Behaviors
Doctorate
49
12.24
87.80
in bedroom
________________________________________________________________________
Item 44. removed from study
________________________________________________________________________
Item 45
Master’s
15
33.33
66.70
.90
When to
Doctorate
48
31.25
68.80
Leave bedroom
________________________________________________________________________
Item 46
Master’s
16
12.50
87.50
.90
Doctorate
50
14.00
86.00
________________________________________________________________________
Item 47 removed from study
________________________________________________________________________
Item 48
Master’s
15
13.33
86.70
.52
Napping
Doctorate
48
20.83
79.17
rule
________________________________________________________________________
Item 49
Master’s
15
13.33
86.70
.17
# of sessions
Doctorate
48
31.30
68.80
sleep hygiene
________________________________________________________________________
Item 50
Master’s
15
13.33
86.70
.60
Sleep hygiene Doctorate
47
19.15
80.90
handouts
________________________________________________________________________
Item 51
Master’s
15
26.67
73.33
.43
CBT-I cog.
Doctorate
46
17.39
82.61
elements
________________________________________________________________________
Item 52
Master’s
15
66.70
33.33
.14
Sleep restric.
Doctorate
47
44.70
55.32
model
________________________________________________________________________
Item 53 -56 removed from study
________________________________________________________________________
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Hypothesis 2
To test whether CBT-I training history predicted practice density, a linear
regression was conducted. The amount of specialized training in CBT-I (number of
reported hours in specialized training in graduate education and continuing education)
was found to be a significant and positive predictor of practice density for the full sample,
R2 = .03, F(1,113) = 5.03, p < .03. Additionally, the amount of reported specialized
training in CBT-I was also a significant and positive predictor of the reported annual total
hours of CBT-I practice, R2 = .03, F(1,117) = 4.20, p < .04 (see Tables 7 and 8).

Table 7
Training History and Practice Density Regression Analysis (Whole Sample)
________________________________________________________________________
Model
Sum of
df
Mean Square
F
Sig
Squares
Regression
164490811
113
1455671
.03
.03*
Residual
Total

7316304
171807115

1

7316304

114

*p < .05

Table 8
Training History and Years Practicing CBT-I Regression Analysis (Whole Sample)
________________________________________________________________________
Model
Sum of
df
Mean Square
F
Sig
Squares
Regression
196216986
117
1677068
4.19
.04*
Residual

7022083

1

7022083

Total
203239069
118
________________________________________________________________________
*p < .05
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When broken down into master’s and doctoral level practitioner subgroups, the
total reported training hours were a significant predictor of the percentage of CBT-I
practice out of reported total clinical practice for the doctoral level practitioners, R2 = .04,
F(1,78) = 3.92, p < .05, but not significant for the master’s level practitioners, R2 = -.03,
F(1,33) = .00, p < .97 (Sees Table 9 and 10). Moreover, the reported hours of specialized
training did not predict the reported total years practicing CBT-I for the doctoral level
practitioners, R2 = .01, F(1,85) = 2.02, p < .20, or master’s level practitioners, R2 = -.03,
F(1,30) = .00, p < .92 (Sees Table 9 and 10). Tables 11 and 12 illustrate the regression
analyses of training history and years practicing CBT-I within the master’s group and
training history and practice density within the doctoral group, respectively.

Table 9
Training History and Practice Density Regression Analysis (Master’s Group)
________________________________________________________________________
Model
Sum of
df
Mean Square
F
Sig
Squares
Regression
10775947
33
326544
.00
.97
Residual

499

1

499

Total
10776446
34
________________________________________________________________________
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Table 10
Training History and Practice Density Regression Analysis (Doctoral Group)
________________________________________________________________________
Model
Sum of
df
Mean Square
F
Sig
Squares
Regression
145437273
78
7313706
3.92
.05*
Residual

7313706

1

7313706

Total
152750979
79
________________________________________________________________________
*p < .05

Table 11
Years Practicing CBT-I Regression Analysis (Master’s Group)
_______________________________________________________________________
Model
Sum of
df
Mean Square
F
Sig
Squares
Regression
24612059
30
820402
.01
.92
Residual

7815

1

7815

Total
24619873
31
________________________________________________________________________

Table 12
Practice Density Regression Analysis (Doctoral Group)
________________________________________________________________________
Model
Sum of
df
Mean Square
F
Sig
Squares
Regression
169391882
85
1992846
2.02
.16
Residual

4034328

1

4034328

Total
173426211
86
________________________________________________________________________
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Hypothesis 3
It was determined that there were not enough participants in each of the
professions to do a complete statistical comparison. Therefore, it was decided that
groups would be broken down into master’s versus doctoral level groups of practitioners.
An independent-samples t-test was conducted to compare the total number of hours of
specialized CBT-I training of doctoral and master’s level clinicians. With regard to total
hours of specialized training, there were significant group differences between doctoral
and master's level practitioners, with doctoral level practitioners having more hours of
specialized CBT-I training (M = 821.21, SD = 1422.80) than master’s level clinicians (M
= 304.81, SD = 833.20), t(126)=2.07, p=.04). Results are illustrated in table 13.

Table 13
Total Training Hours t-test to Determine Variance between Master’s and Doctoral Level
Practitioners
________________________________________________________________________
Mean
SD
N
DF
T
sig.
________________________________________________________________________
Master’s
304.81
833.20
37
126
2.07
.04*
Doctorate
821.21
1422.80
91
________________________________________________________________________
*p < .05

There were also significant group differences with regard to practice density, or
the total percentage of CBT-I hours practiced annually out of total practice hours.
Doctoral level practitioners reported a higher practice density (M = 39.93, SD = 31.70)
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than the master’s level group (M = 24.40, SD = 31.90), t(146) = 2.72, p = .01. Results are
shown in Table 14.

Table 14
Practice Density: Percent of CBT-I Practice out of Total Practice: t-test to Determine
Variance between Master’s and Doctoral Level Practitioners
________________________________________________________________________
Mean
SD
N
DF
T
sig.
________________________________________________________________________
Master’s
24.40
31.90
44
146
2.72
.01*
Doctorate
39.93
31.70
104
________________________________________________________________________
*p < .05

There were also significant group differences between groups in the total number
of years applying CBT-I, with doctoral practitioners reporting more years applying CBTI (M = 9.20, SD = 6.70) than master’s level practitioners (M = 3.70, SD = 3.50), t(148) =
4.93, p = .0001). Table 15 depicts this.

Table 15
Years Practicing CBT-I: t-test to Determine Variance between Master’s and Doctoral
Level Practitioners
________________________________________________________________________
Mean
SD
N
DF
T
sig.
________________________________________________________________________
Master’s
3.7
9.30
41
148
4.93
.00*
Doctorate

9.2

11.20

109

________________________________________________________________________
*p < .05
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There were no significant between-group differences with regard to reported
adherence to empirically validated protocols, with doctoral level practitioners (M = 64.02,
SD = 22.20) scoring similarly to master’s level practitioners (M = 66.34, SD = 24.1),
t(83) = 2.72, p = .66. The score represents the percentage of total correct answers on the
practice questionnaire (See Table 16).

Table 16
Adherence Percentage: t-test to Determine Variance between Master’s and Doctoral
Level Practitioners
________________________________________________________________________
Mean
SD
N
DF
T
sig.
________________________________________________________________________
Master’s
66.34
24.1
27
83
-.44
.66
Doctorate

64.02

22.2

58

________________________________________________________________________
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Chapter 6: Discussion

Previous research found significant deficits in educational curricula regarding
insomnia and its treatment, with some professions, such as those in the medical field,
receiving more training than graduate psychology programs (Lichstein et al., 1998;
Meltzer et al., 2009; Moline & Zendell, 1993). Additionally, there is great variability in
how doctoral programs in clinical psychology train students in behavioral sleep medicine,
with some programs offering explicit CBT-I training and others providing little or no
instruction on insomnia, beyond considering it as a secondary symptom of other disorders
(Lichstein et al., 1998). Although there have been a few studies exploring the extent to
which graduate students were trained in insomnia treatment such as CBT-I, a review of
the literature reveals minimal research to date examining how the differences in training
impact clinical practice, specifically with regard to CBT-I treatment. The absence of
literature pertaining to how training impacts the application of the empirically validated
CBT-I represents a significant limitation in the existing literature.
This study examined how the amount of CBT-I education influenced the
knowledge and application of CBT-I. More precisely, researchers examined how the
total number of hours of specialized professional training in CBT-I predicted knowledge
and practice of CBT-I (percentage of correct answers on the practice questionnaire) and
practice density (percentage of annual CBT-I practice out of annual total practice and the
number of years practicing CBT-I). The sample included 165 participants consisting of
73% females and 27% males. Although the majority of the participants were from the
United States (n = 143), there was also some international participation.
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The existing literature indicates that there are substantial differences in the
amount and type of training medical and mental health professionals receive for the
assessment and treatment of insomnia (Meltzer et al., 2009). Overall, the results of the
present study demonstrate that practitioners who obtained more training in CBT-I are
significantly more likely to apply CBT-I, treat more cases as evidenced by the number of
hours practicing, and have practiced CBT-I for longer periods. Although there were
many similarities, some differences between practitioners with master’s versus doctoral
degrees were noted.
The State of Education in Insomnia and CBT-I
In 2009, only 6% of psychology training programs offered formal didactic courses
in behavioral sleep medicine, and 31% of training programs offered some education in
treating sleep disorders. Overall, training programs are understaffed with professionals
who are knowledgeable about insomnia and other sleep disorders, with only 16% of the
programs polled reporting that they have faculty trained in sleep medicine (Meltzer et al.,
2009). Although the training for psychology students is limited, approximately 39% of
training directors believe education in insomnia treatment should be a mandatory part of
the curriculum (Meltzer et al., 2009). The present study sought to illuminate the current
state of education in behavioral sleep medicine, specifically regarding the impact of
CBT-I training on the professional practice of those providing insomnia treatment.
The present study assessed the participants (N = 165) to examine how the number
of hours of advanced training impacted the knowledge and practice of CBT-I (percentage
of correct answers on the practice questionnaire) and practice density (percentage of
annual CBT-I practice out of annual total practice and the number of total of years
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practicing CBT-I). All participants were professionals who received advanced training in
CBT-I. These practitioners reported attaining a variety of degrees, including BA, BS,
MA, MS, RN, MSN, MSW, LCSW, NP, Psy.D., Ph.D., DO, MD, RST, and Other.
Findings and Clinical Implications
With regard to the first hypothesis, this study found that among practitioners who
received CBT-I training, the total hours of training alone did not predict increases in
adherence to EBP in the sample as a whole. Post-hoc analysis was conducted to
determine whether there were significant differences among practitioners with differing
levels of education, that is, master’s versus doctoral level clinicians. There was a clear
disparity in the amount of training in behavioral sleep medicine generally and CBT-I
specifically among mental and medical professionals, with the mean number of hours of
total training for the master’s clinicians being 304.8 and the mean for the doctoral
clinicians being 821.2. The results also demonstrated that training hours alone did not
significantly predict knowledge of CBT-I between groups of practitioners (master’s and
doctoral level practitioners). CBT-I knowledge was measured by the percent of correct
answers on the questionnaire, which measured reported adherence to empirically
validated protocols. The previous literature pertaining to the impact of training and years
of experience on symptom reduction, therapeutic effectiveness, and clinician attitudes
about treatment is mixed. Some studies suggested that the level of training does not
impact a practitioner’s ability to treat insomnia symptoms (Forand et al., 2011). Other
findings on practitioner competency demonstrate that more experienced practitioners
achieve greater anxiety symptom reduction when applying CBT (Branson et al., 2015).
To date, the same research methodology that examined the efficacy of a practitioner
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applying CBT has not been applied to CBT-I. It should be noted that the present study
assessed practitioners’ knowledge and not the clinical outcomes. Consequently, it is
possible that if the two groups of practitioners, master’s and doctoral, were compared
based on level of training, the application of the CBT-I would result in a differential
patient outcome.
More globally, the lack of statistically significant differences between master and
doctoral level clinicians regarding the number of training hours and knowledge of CBT-I
indicates that specialized training in CBT-I may quickly and efficiently impart key
knowledge resulting in greater impact on reported adherence to EBP than does much
more prolonged and costly formal academic training, especially when such training does
not address insomnia treatment specifically, as is the case with most programs surveyed.
Given the high prevalence of insomnia and the efficiency of clinical training, the data
would suggest that all graduate programs should, at a minimum, provide some education
in EBPs such as CBT-I, because even modest levels of training may make it likely that
practitioners will become knowledgeable in this EBP.
There are a number of possible explanations as to why training history did not
predict adherence to EBP. First, because all of the participants were trained in CBT-I,
having attended at least one specialized training, it is likely that participants learned
relevant material during that time and that the questionnaire was a valid measure of that
knowledge. If this is the case, then results seem to indicate that specialized CBT-I
training resulted in and was more predictive of adherence to and knowledge of CBT-I
than the level of education (master’s vs. doctoral degree). These results could be
interpreted to mean that proper, focused, expert CBT-I training is necessary and sufficient

EVIDENCE BASED CBT-I

69

to attain such knowledge and that CBT-I training is so effective that even a limited
number of expert CBT-I training sessions result in greater knowledge and adherence to
EBP than does years of more general academic training, as indicated by a lack of
statistical difference between master's and doctoral level practitioners. This may mean
that, although advanced academic training is necessary, the current curriculum does not
appear to be sufficient to learn evidence-based CBT-I.
Another possible explanation for the results is that, because both groups of
practitioners (master’s and doctoral) similarly omitted specific components of evidencebased protocols or incorrectly answered items similarly between groups, their scores were
correspondingly suppressed. One surprising example is that the majority of participants
omitted sleep hygiene as a necessary component of evidence-based CBT-I. Additionally,
many practitioners reported using incorrect formulas to calculate essential elements of
CBT-I. Errors included essential components of SRT, such as prescribed time in bed and
prescribed time to bed. The fact that these formulas were not used properly indicates a
lack of knowledge and possibly an absence of adherence to common components of
evidence-based CBT-I (Edinger & Carney, 2015; Manber & Carney, 2015; Morin &
Espie, 2003; Perlis et al., 2008).
It is also possible that each practitioner independently evaluated the importance of
sleep hygiene and its impact on treatment outcomes and chose to exclude this component.
It is also possible that practitioners’ training deemphasized the sleep hygiene, in favor of
standalone EBP packages (SCT, SRT, and CBT-I), all which incorporate essential sleep
hygiene elements. On the other hand, many practitioners might assume that sleep
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hygiene is an implicit part of CBT-I and not necessary to include; because sleep hygiene
by itself has not been demonstrated to be a standalone EBP.
Because common errors occurred regardless of the level of training in both
academia and CBT-I-specific training, this study illuminates important areas that CBT-I
trainers may now want to focus on more closely for beginners, advanced, and follow-up
training. Most practitioners incorrectly answered the question regarding the accepted
evidence-based recommendations for the prescribed time in bed and prescribed time to
bed. Examples of incorrect responses for the prescribed time in bed included “rough
guess” and, “using a calculator and computer program.” Examples of incorrect responses
for the prescribed time to bed include “not sure” and “when feeling sleepy.”
Although practitioners’ inability to identify the correct formulas for the prescribed
time in bed and prescribed time to bed could reflect a lack of practical knowledge of one
of the most essential elements of the SRT component of treatment CBT-I or, more
optimistically, this may demonstrate the growing popularity and dependence on
spreadsheet programs that do the calculations for the practitioner. Of course, lack of
knowledge and improper calculation could result predictably in the faulty application of
SRT recommendations, such as prescribed time in bed and time to bed. Conversely,
using technology for calculations could compensate for this lack of technical knowledge
(calculations) and may result in more accurate calculations by reducing human error.
It is also possible some of the response errors were the result of the wording of
some of the items that were confusing, which was indicated by one such response, “I
don't understand the question.” Of course, the admission of uncertainty by this
participant could be a reflection of the absence of knowledge or confusion with the
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wording, which may have caused a higher than expected error rate on items 31 (When
conducting CBT-I, what treatments do you typically use), 34 (How do you assess and
determine prescribed time in bed [PTIB], i.e., prescribed sleep opportunity), and 42
(When conducting sleep restriction, the rule I use to define time to bed is
________________.).
Regarding the absence of sleep hygiene as an essential component, the reason
many practitioners may have likely omitted this item is that it is not a standalone
intervention. The wording of the question asked for “treatments that are typically used.”
The intended wording of the question was to assess both practitioners’ knowledge and
also their real-life application of the empirically validated protocol. The data suggest that
practitioners do not view sleep hygiene as an essential part of CBT-I. It should also be
noted that many practitioners included mindfulness as an essential component, though
mindfulness is not a formal part of the validated protocol. Given the frequency of
mindfulness inclusion, additional research should be conducted to assess how the formal
inclusion of mindfulness into the CBT-I protocol enhances treatment from a symptom
reduction perspective. Additional research regarding the presence or absence of sleep
hygiene should also be conducted in order to further understand why some practitioners
do not include it and the impact the absence or presence of sleep hygiene has on the
remission of insomnia symptoms.
Participants scored between 60% and 70% correct responses on questions related
to CBT-I knowledge. The skew of the data could be representative of the distribution of
participants, with some individuals scoring high on the questionnaire and other
participants scoring low, thereby skewing the mean. When the knowledge percentage
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scores were compared between groups (master’s and doctoral), there was no significant
difference between groups with respect to correct versus incorrect responses on the
knowledge questionnaire. The absence of statistically significant differences implies that
another possible reason for the error rates could be that there were some items on the
questionnaire that was more difficult for all participants. The exact reason why said
items were difficult is unknown.
With regard to hypothesis 2, this study demonstrated that practitioners who have a
greater number of hours of CBT-I training apply CBT-I significantly more, as measured
by greater practice density (total number of hours of CBT-I out of total clinical hours of
practice) and had a significantly higher total number of years practicing CBT-I than those
with less training. Manber et al. (2013) found that individuals who received formal
training in CBT-I reported higher ratings of skill-specific self-efficacy and increased
positive attitudes toward CBT-I than individuals who did not receive training. These
results support the need for early evidence-based CBT-I training in educational settings
and supplementary training so that practitioners can increase self-efficacy and refine their
skill sets so that they may incorporate evidence-based CBT-I into their clinical work
earlier in their careers if they desire to treat more CBT-I patients in clinical practice.
Post-hoc regression analyses between the master’s and doctoral groups
demonstrated that the hours of training predicted the practice density for the doctoral
practitioners but not for the master’s group. This means that doctoral level practitioners
who receive more training tend to incorporate the clinical application of CBT-I more into
their caseload than master’s practitioners. The amount of training was not predictive of
the number of years of practicing CBT-I for master’s or doctoral groups. It is possible
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that the very nature of being in school longer contributed to the prediction that the
amount of training causes more CBT-I practice percentage out of the total clinical
practice; however, researchers do not consider the longer training as the primary reason
for this. The immediate application of a specialized treatment early in doctoral training is
uncommon. Many programs do not start field experience until a practitioner has
demonstrated his or her knowledge and competencies, which may happen in the second
or third year of a doctoral program. The fact that many doctoral programs do not start
field placement until later in training conflicts with the idea that 5 years of schooling
inevitably equates to 5 years CBT-I application.
One possible reason for why the amount of training was not a significant predictor
of the number of years of practicing CBT-I respective of subgroups is that the sample
may have included practitioners who research more than they practice. Another possible
explanation is that some of the practitioners may have more training hours in order to
comply with state continuing education (CE) requirements for licensure, but may have no
intention of applying CBT-I to their respective clinical practice.
It must also be noted that, when broken down into subgroups during post-hoc
analyses, the variables of interest (years practicing CBT-I and the percentage of CBT-I
therapy hours out of total clinical hours) were significant only for the doctoral level
clinicians but not for those with master’s degrees. Upon reviewing the data, the master’s
group had far fewer training hours on average, which made it more difficult for the
analyses to predict the variables of interest. It should also be noted that the master’s
group was underpowered when compared the doctoral level group, which may also have
impacted the ability of the selected analyses to detect significance. Also related to
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hypothesis 2, there were instances in which the training hours appeared exaggerated.
Given the mean standard deviation for the whole sample relative to the total number of
training hours in CBT-I, it is possible that some practitioners attempted to provide an
approximation of their training experience as was requested by the questionnaire.
Hypothesis 3 demonstrated that there are significant group differences with regard
to the number of hours practitioners are trained in CBT-I, the number of hours the
clinicians practiced CBT-I, and the number of years the practitioners practiced CBT-I.
There were no significant group differences with regard to the knowledge of CBT-I.
Limitations
The current study may have been limited by a number of factors. For example,
the sample selection process and recruitment relied heavily on CBT-I listservs that were
comprised of CBT-I trained psychological and medical professionals. Although the
sample size is fairly large, the database of therapists was limited to practitioners who
received training from independent training seminars, but also seminars that overlapped
in terms of educational content. Because some of the practitioners were taught by
common programs, one could hypothesize that the results yielded a higher level of
knowledge of CBT-I and increased practice density than would have occurred if
compared to a control group of students and professionals who had not received
specialized formal training. The selection of the sample of practitioners who were trained
in CBT-I may limit the generalizability of the study and may underestimate the
magnitude of the CBT-I training effects for this population, in that there may have been a
very high floor effect in this sample than would have been seen if we had compared those
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with specialized CBT-I training to professionals with more general clinical education or
other specialized types of behavioral sleep medicine training.
Many VA clinicians receive specialized CBT-I and training, and utilization rates
are high among VA clinicians. The success of CBT-I for insomnia among the VA
population is notable, with one study demonstrating average scores for individuals with
insomnia symptoms decreased on average from 20.7 to 10.9 on the Insomnia Severity
Index from pre- to post treatment (Trockel, Karlin, Taylor, & Manber, 2014).
Unfortunately, it appears that VA therapists were underrepresented in the study, further
limiting the generalizability of the current study.
One should also note that, when comparing practice density and hours of training,
all types of training are not equal and the type of clinical intervention each practitioner
engaged in may differ significantly. Although the hours of training and type of practice
may be convenient metrics, the actual content of the training and types of clinical settings
in which the practice hours were attained may be quite different. Moreover, the study did
not measure patient outcome or the relevant variables that predict it.
Future Directions
The implications of the results are highly applicable to counseling and doctoral
level training. Given the worldwide near-epidemic of sleep deprivation and insomnia and
the high prevalence in clinical populations, it is incumbent upon medical and mental
health professionals to be trained in treating, or at least properly referring individuals for
adequate treatment. Luckily, there is an EBP available. Ideally, all mental health
clinicians and relevant medical practitioners could be trained adequately for these
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purposes, so that practitioners could incorporate validated insomnia interventions, such as
CBT-I, into their practices for the benefit of their patients.
From these results, it seems clear that training might be improved with some
modification, as most of the practitioners reported some errors in adhering to evidencebased protocols, as demonstrated by the median scores for all practitioners on the
questionnaire scoring between 60% and 70% on adherence. The existing literature
demonstrated that there are differences in how strictly practitioners apply certain
interventions, with more experienced practitioners adhering more strictly than their less
experienced counterparts (Campbell et al., 2013). Campbell et al.’s (2013) findings are
relevant to the present study because there appears to be similar knowledge between
groups of practitioners with different amounts of training. It may be necessary for future
research to examine how the amount of training impacts the application of CBT-I in an
observable, measurable way and how those differences in application relate to the
reduction in insomnia.
Moreover, investigating how insomnia interventions are being applied in
outpatient community behavioral health settings, inpatient psychiatric hospitals, and other
treatment settings would be important. Finally, the value of specialized training, level of
practical knowledge, and adherence to EBPs may become clearer when CBT-I trained
clinicians are compared to those with more general clinical education or other specialized
types of behavioral sleep medicine training.
Conclusion
It is clear that there is a disparity in the amount of training in behavioral sleep
medicine generally and CBT-I specifically among mental health and medical
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professionals, with the mean number of hours of total training for the master’s clinicians
being 304.8 and the mean for the doctoral clinicians being 821.2. Although there is a
large disparity in the number of hours, the amount did not translate into a difference in
knowledge, as evidenced by the scores on the practice questionnaire being relatively
similar. This is good news for the mental health field because it means that even a
modest amount of specialized training can have a large impact on how much practitioners
know about the CBT-I protocol.
The findings also demonstrate that clinicians increase the hours of CBT-I practice
when they attain more hours of training. The results suggest that clinicians who obtain
more specialized CBT-I training report treating a higher percentage of insomnia patients
in their caseloads and report more years of treating insomnia patients. This is important
to note because it could be evidence that individuals with more training are more likely to
apply evidence-based CBT-I, which hopefully translates to more availability of
empirically validated interventions.
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Appendix B

Free Response Coding Rules, CBT-I Questionnaire
Mark D. DelGuercio, Dr. Brad Rosenfield, Dr. Michael Perlis, Dr. David Festinger
General instructions: Progress sequentially through each participant’s responses. Follow
explicit directions for each question and code EXACTLY as directed. If answers are not
provided in the acceptable answer list (located directly beneath the question) or if
instructions do not specifically instruct the scorer to accept variations of the list, answers
should be marked incorrect.
31. (a-d) When conducting CBT-I, what treatments do you typically use?
4 points possible, 1 point per correct answer
Acceptable answers:
 Sleep hygiene
 Sleep restriction
 Stimulus control
 Cognitive restructuring/ thought disputation/decatastrophizing (CT in relation to
adherence problems. any variation of addressing cognitive elements impacting
sleep)
32. When conducting assessments for CBT-I, what instruments (measures) do you
consider to be essential?
1 point possible. 1 point is awarded for journal/sleep diary/sleep log (1 point). If the
participant gives just journal it’s 1 point and if they give any of the below listed
assessments without sleep journal it is 0 points. Assessments not listed in the list below
do not negatively impact the score but are not awarded a point.
Acceptable answers:
 A Sleep Environment Checklist
 Actigraphy
 Caffeine Knowledge Quiz
 Dysfunctional Beliefs About Sleep Scale (DBAS)
 Epworth Sleepiness Scale (ESS)
 Insomnia Severity Index (ISI)
 Insomnia Symptom Questionnaire
 Medical History Checklist
 Motivation for Change Index
 Multi Factorial Fatigue Inventory (MFFI)
 Multiple sleep Latency Test (MSLT)
 Polysomnopraph
 Sleep Disorders Symptoms Checklist
 Symptom Checklist
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Sleep diary
Sleep Environment Checklist
The Sleep Behavior Scale
The Insomnia Severity Scale (ISI)
The Pittsburg Sleep Quality Index (PSQI)
The Pre-Sleep Arousal Scale
The Sleep Disturbance Questionnaire
The Sleep Hygiene Practice Scale

33. How is sleep efficiency calculated? (please specify the formula and the manner in
which you calculated e.g spread sheet, calculator)
1 point for any of the answers listed below (manner in which the score is calculated does
not influence the point awarded in any way):
Acceptable answers:
 (TST/TIB)x100
 percentage of time asleep relative to the time allotted for sleep 100* (TST/TIB)
 ratio of time asleep over time spent in bed multiplied by 100
 sleep efficiency is calculated by dividing the patient’s average total sleep time by
the average time spent in bed and then multiplying by 100
34. How do you assess and determine prescribed time in bed (PTIB), i.e., prescribed
sleep opportunity? (Answer must include the word average to be marked correct)
**note that “sleep ability” is an acceptable alternative to “average” because “sleep
ability” is calculated using averages.
Acceptable answers:
 Average time from time to bed to time out of bed
 Average total TST in the past week rounded to the nearest quarter hour
 Average total sleep time+30minuntes
35. At baseline, when assessing TIB (average sleep opportunity), ideally how many days
of sleep diary data should be used?
Acceptable Answers (Between 1 & 2 weeks). Responses provided in the equivalent
number of days are acceptable as long as it’s between 7 and 14 days. Exactly 7 and
exactly 14 are also permissible.
Acceptable answers:
 Usually 1-2 weeks
 2 weeks preferred, can use 1 week
 1-2 weeks
 2 weeks
36. During the course of treatment, the calculation of sleep efficiency should be based on
how many days/weeks of sleep diaries (minimum)?
* if more than one answer is given and one of the answers is wrong, the answer is
incorrect. (Ex. “I prefer 7days but use 3 days”).
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**If answer is less than seven and no unit of measure of time is provided the answer
should be marked incorrect.
Acceptable answers:
 1 week minimum (7 days)
 the amount of time since the last appointment (cannot not be less than 7 days
or 1 week)
*If response refers to the “time since last appointment” but does not specific the
amount of time since the last appointment the answer should be marked incorrect
37. When applying Sleep Restriction, and using sleep efficiency% (SE%), what do you
use for the threshold for upward titration of PTTB?
**Please note that the range 85-90% is not an acceptable answer and should be
marked incorrect.
Acceptable answers:
 >90%
 90%
 85%.
38. When applying Sleep Restriction, and using sleep efficiency %(SE%), what do you
use for the threshold for downward titration of PTTB? * if multiple answers are given
and one of them is wrong, mark the answer wrong.
Acceptable answers:
 SE% < 85
 80%
39. When applying Sleep Restriction, and using sleep efficiency (SE%), what do you use
for the threshold for no change in PTTB? **if participant provides a rang of scores
outside of the range of acceptable answers mark as incorrect. When tracking
frequency distributions, if the range overlaps with an existing category, select the
category that most clearly reflects the incorrect versus correct response.
Acceptable answers:
 Between 85% and 90%
 80-85% (was >80% before 11.7.17)
 If the patient is sleep soundly most nights and feeling alert in the daytime,
then no TIB adjustment is needed
40. When applying Sleep Restriction, what increment is used for upward titration of
PTTB?
Acceptable answers:
 15 minutes
 15 minutes OR 30 minutes if sleepiness is present
(if the participant uses thirty minutes they MUST indicate that sleepiness is
present or explain a general reason for extending the increment to 30min)
41. The frequency with which CBT-I sessions should occur (optimally) is ______?
Acceptable answers:
 Once per week for 4-8 weeks

EVIDENCE BASED CBT-I



121

Bi weekly
Weekly at first then bi weekly. Periodic booster sessions can also be
scheduled

42. When conducting sleep restriction, the rule I use to define time to bed is
______________
Acceptable answers:
 Desired time of awakening-average TST
 Wake time-TIB
 Morning rising time-Average sleep time
*acceptable answers may include the term (PTIB=prescribed time in bed interchangeably
with total sleep time). It should be noted that (PTIB) in some protocol permit adding 30
minutes. Thus, desired awakening – PTIB +30 minutes is an acceptable answer.
43. According to the principles of stimulus control, what behaviors are permitted in the
bedroom?
Acceptable Answers:
 Sleep and sex
 Sleep
44. What behaviors are permitted during the practice of stimulus control (outside the
bedroom)?
Acceptable answers:
 Any normal activity
 Pleasurable normal activities
 Pleasant engaging activities that are not too activating
45. What are the instructions for when to leave the bedroom in the event that a patient
cannot sleep?
Acceptable Answers:
 When they are awake and they know it or when they are annoyed
 When they are awake and know it
 15min
 10-15min
 20 minutes or so (or so in this context is anything within 5 minutes of 20
minutes)
*because “or so” includes a 5 minute span of time (any answer from 10-20 is
acceptable)
46. When is it appropriate to return to the bedroom?
Acceptable answers:
 Return only when sleepy (answer must include the word sleepy)
 Return to bed after 20 minutes (modified recommendation
 Tired/fatigued are not acceptable unless used in combination with “sleepy” or
“drowsy” or a description of physiological manifestation of sleepiness.
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Describing symptoms of sleepiness and drowsiness is also an acceptable
answer (ex. Having trouble keeping eyes open). Groggy is also acceptable as
it is, by definition, representing weakness associated with sleep.
“ready for sleep” is unacceptable because it does not indicate a feeling of
sleepiness and could be representative of intent and not physiological
preparedness for sleep

47. How do you determine the prescription for time in bed?
Acceptable answers:
(not scored)  overlap with question 14
48. According to standard stimulus control instructions, the rule with respect to napping
is
________?
Acceptable Answers:
 Prohibited
 Do not nap
 Avoid daytime napping
 Avoid naps but stopping naps is better
** answer must include a reference to prohibiting napping or avoiding it. If the
answer has an elaboration on the restrictions on the napping or a duration of nap
time in combination with the words that describe prohibition it is acceptable
because it is reflective of the desire to avoid.
49. Ideally, how many sessions should be devoted to sleep hygiene?
Acceptable Answer:
 >0, less than 1
 Anything more than 0 or none
*If no number or duration of time is given the answer is wrong
*ranges occurring outside of one such as 1-2 are marked wrong
50. If a handout for sleep hygiene is provided to patients what are key elements that
should be
included________?
Acceptable answers: (any combination of the below listed).
*answers such as “environment” and “bedroom” should be marked wrong
because they
they don’t sufficiently explain how each relates to sleep.
 Do no try to fall asleep
 But clock under bed
 Avoid naps
 Don’t take problems to bed
 Avoid excessive liquids
 Do not go to bed hungry (eat regular meals)
 Get up at the same time every day seven days per week
 Only sleep as much as you need to feel refreshed
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Limit caffeine
limit nicotine
limit alcohol
manage diet
manage noise
manage exercise
manage room temp
manage body temp
improve air quality
limit light
improve bed comfort

51. Cognitive elements of CBT-I may include _____________________________?
Acceptable answers:
 worrying
 beliefs about safety behaviors
 unrealistic expectations of sleep
 constructive worry
 catastrophic thinking
*Answers such as “challenging thoughts” are not sufficient because they do not
accurately describe cognitive restructuring and restructuring catastrophic
ideations. Such answers should be marked incorrect.
*Answers that only list common tools of CBT such as “thought records etc”
should be marked incorrect unless accompanied by the aforementioned acceptable
answers.
52. When explaining the rationale for sleep restriction, what if any model do you use to
explain the concept to the patient?
Acceptable answers:
 circadian rhythm & homeostatic sleep drive (two process model)
o A description of these two processes are an acceptable answer
o (must explain both processes or the answer should be marked incorrect)
 three process (3P)
 (4P)
53. What are common patient resistances? Name three.
Acceptable answers
(not scored)
54. What recommendations do you typically make with respect to relapse prevention?:
Acceptable Answers:
(not scored)
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55. Is there a component or measurement that has not been inquired about in this
questionnaire that you believe is critical to the conduct of CBT-I?
Acceptable answers:
(not scored)
56. Is there anything pertaining to training and practice of behavioral sleep medicine that
we didn't ask that would we should have?
Acceptable answers:
(not scored)

